CA2551412A1 - Transition metal complexes of n-heterocyclic carbenes, method of preparation and use in transition metal catalyzed organic transformations - Google Patents
Transition metal complexes of n-heterocyclic carbenes, method of preparation and use in transition metal catalyzed organic transformations Download PDFInfo
- Publication number
- CA2551412A1 CA2551412A1 CA 2551412 CA2551412A CA2551412A1 CA 2551412 A1 CA2551412 A1 CA 2551412A1 CA 2551412 CA2551412 CA 2551412 CA 2551412 A CA2551412 A CA 2551412A CA 2551412 A1 CA2551412 A1 CA 2551412A1
- Authority
- CA
- Canada
- Prior art keywords
- group
- reaction
- compound according
- substituted
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 61
- 229910052723 transition metal Inorganic materials 0.000 title claims abstract description 16
- 150000003624 transition metals Chemical class 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title abstract description 8
- 238000000844 transformation Methods 0.000 title description 3
- 230000009466 transformation Effects 0.000 title description 2
- 150000001875 compounds Chemical class 0.000 claims abstract description 89
- 239000003054 catalyst Substances 0.000 claims abstract description 52
- 238000006880 cross-coupling reaction Methods 0.000 claims abstract description 46
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 23
- 238000006243 chemical reaction Methods 0.000 claims description 84
- -1 OC1-20alkyl Chemical group 0.000 claims description 36
- 125000003118 aryl group Chemical group 0.000 claims description 36
- 239000003446 ligand Substances 0.000 claims description 33
- 239000011541 reaction mixture Substances 0.000 claims description 24
- 239000002904 solvent Substances 0.000 claims description 24
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 22
- 239000000758 substrate Substances 0.000 claims description 21
- 229910052760 oxygen Inorganic materials 0.000 claims description 20
- 125000001424 substituent group Chemical group 0.000 claims description 19
- 125000005842 heteroatom Chemical group 0.000 claims description 17
- 229910052717 sulfur Inorganic materials 0.000 claims description 17
- 229910052739 hydrogen Inorganic materials 0.000 claims description 16
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 15
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 15
- 125000005843 halogen group Chemical group 0.000 claims description 14
- 125000001072 heteroaryl group Chemical group 0.000 claims description 13
- 239000007787 solid Substances 0.000 claims description 13
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 12
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 12
- 238000006411 Negishi coupling reaction Methods 0.000 claims description 11
- 229910052794 bromium Inorganic materials 0.000 claims description 10
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 10
- 229910052763 palladium Inorganic materials 0.000 claims description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 9
- 125000004429 atom Chemical group 0.000 claims description 9
- 238000005859 coupling reaction Methods 0.000 claims description 9
- 125000001153 fluoro group Chemical group F* 0.000 claims description 9
- ADLVDYMTBOSDFE-UHFFFAOYSA-N 5-chloro-6-nitroisoindole-1,3-dione Chemical compound C1=C(Cl)C([N+](=O)[O-])=CC2=C1C(=O)NC2=O ADLVDYMTBOSDFE-UHFFFAOYSA-N 0.000 claims description 8
- 125000004122 cyclic group Chemical group 0.000 claims description 8
- 229910052751 metal Inorganic materials 0.000 claims description 8
- 239000002184 metal Substances 0.000 claims description 8
- 125000002950 monocyclic group Chemical group 0.000 claims description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 8
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 8
- 238000006069 Suzuki reaction reaction Methods 0.000 claims description 7
- 125000000129 anionic group Chemical group 0.000 claims description 7
- 229910052757 nitrogen Inorganic materials 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 7
- 238000006443 Buchwald-Hartwig cross coupling reaction Methods 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 6
- 229910052740 iodine Inorganic materials 0.000 claims description 6
- 229910052697 platinum Inorganic materials 0.000 claims description 6
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 6
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 5
- 229910052731 fluorine Inorganic materials 0.000 claims description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- 229910052703 rhodium Inorganic materials 0.000 claims description 5
- 238000005577 Kumada cross-coupling reaction Methods 0.000 claims description 4
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 claims description 4
- 150000001450 anions Chemical class 0.000 claims description 4
- 229910052741 iridium Inorganic materials 0.000 claims description 4
- 229910052742 iron Inorganic materials 0.000 claims description 4
- XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 claims description 4
- 229910052707 ruthenium Inorganic materials 0.000 claims description 4
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 3
- 238000003477 Sonogashira cross-coupling reaction Methods 0.000 claims description 3
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 claims description 3
- 238000006254 arylation reaction Methods 0.000 claims description 3
- 238000004587 chromatography analysis Methods 0.000 claims description 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 3
- 238000000746 purification Methods 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- 238000006467 substitution reaction Methods 0.000 claims description 3
- 125000006704 (C5-C6) cycloalkyl group Chemical class 0.000 claims description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 2
- 238000003692 Hiyama coupling reaction Methods 0.000 claims description 2
- 238000006619 Stille reaction Methods 0.000 claims description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 2
- 238000005810 carbonylation reaction Methods 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 238000007037 hydroformylation reaction Methods 0.000 claims description 2
- 238000006459 hydrosilylation reaction Methods 0.000 claims description 2
- 229910052759 nickel Inorganic materials 0.000 claims description 2
- 229910052762 osmium Inorganic materials 0.000 claims description 2
- 238000001953 recrystallisation Methods 0.000 claims description 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 7
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 claims 5
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 4
- 125000006651 (C3-C20) cycloalkyl group Chemical group 0.000 claims 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims 1
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 claims 1
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims 1
- LVZWSLJZHVFIQJ-UHFFFAOYSA-N Cyclopropane Chemical compound C1CC1 LVZWSLJZHVFIQJ-UHFFFAOYSA-N 0.000 claims 1
- 235000010216 calcium carbonate Nutrition 0.000 claims 1
- 235000015320 potassium carbonate Nutrition 0.000 claims 1
- 235000017550 sodium carbonate Nutrition 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 abstract description 20
- 239000012041 precatalyst Substances 0.000 abstract description 17
- 238000011065 in-situ storage Methods 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 3
- 230000006872 improvement Effects 0.000 abstract description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 39
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 24
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 23
- 239000000243 solution Substances 0.000 description 22
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 16
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 16
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 15
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 239000000047 product Substances 0.000 description 14
- 238000003818 flash chromatography Methods 0.000 description 12
- 238000003756 stirring Methods 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 11
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 10
- 229910000024 caesium carbonate Inorganic materials 0.000 description 10
- 150000008282 halocarbons Chemical class 0.000 description 10
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 10
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 9
- 230000008901 benefit Effects 0.000 description 9
- 229910052799 carbon Inorganic materials 0.000 description 9
- 238000011156 evaluation Methods 0.000 description 9
- 229910052786 argon Inorganic materials 0.000 description 8
- 239000003153 chemical reaction reagent Substances 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 238000001035 drying Methods 0.000 description 7
- 239000011261 inert gas Substances 0.000 description 7
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 7
- PWRBCZZQRRPXAB-UHFFFAOYSA-N 3-chloropyridine Chemical compound ClC1=CC=CN=C1 PWRBCZZQRRPXAB-UHFFFAOYSA-N 0.000 description 6
- 150000001347 alkyl bromides Chemical class 0.000 description 6
- 230000008878 coupling Effects 0.000 description 6
- 239000007819 coupling partner Substances 0.000 description 6
- 238000010168 coupling process Methods 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000000741 silica gel Substances 0.000 description 6
- 229910002027 silica gel Inorganic materials 0.000 description 6
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
- 239000004809 Teflon Substances 0.000 description 5
- 229920006362 Teflon® Polymers 0.000 description 5
- 230000004913 activation Effects 0.000 description 5
- 239000012267 brine Substances 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000005457 optimization Methods 0.000 description 5
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 5
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 5
- 125000002827 triflate group Chemical group FC(S(=O)(=O)O*)(F)F 0.000 description 5
- RSJKGSCJYJTIGS-UHFFFAOYSA-N undecane Chemical compound CCCCCCCCCCC RSJKGSCJYJTIGS-UHFFFAOYSA-N 0.000 description 5
- 235000016804 zinc Nutrition 0.000 description 5
- 238000005481 NMR spectroscopy Methods 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- QARVLSVVCXYDNA-UHFFFAOYSA-N bromobenzene Chemical compound BrC1=CC=CC=C1 QARVLSVVCXYDNA-UHFFFAOYSA-N 0.000 description 4
- 230000003197 catalytic effect Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 4
- 229960005235 piperonyl butoxide Drugs 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 4
- 229910052725 zinc Inorganic materials 0.000 description 4
- 239000011701 zinc Substances 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- COERJHDMQUPDCV-UHFFFAOYSA-N [K].FB(F)F Chemical class [K].FB(F)F COERJHDMQUPDCV-UHFFFAOYSA-N 0.000 description 3
- 150000001500 aryl chlorides Chemical class 0.000 description 3
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000010494 dissociation reaction Methods 0.000 description 3
- 230000005593 dissociations Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 150000003003 phosphines Chemical group 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000006894 reductive elimination reaction Methods 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000006478 transmetalation reaction Methods 0.000 description 3
- VQGHOUODWALEFC-UHFFFAOYSA-N 2-phenylpyridine Chemical compound C1=CC=CC=C1C1=CC=CC=N1 VQGHOUODWALEFC-UHFFFAOYSA-N 0.000 description 2
- 238000005712 Baylis-Hillman reaction Methods 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- 101150041968 CDC13 gene Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000007818 Grignard reagent Substances 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical class CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- 229910002666 PdCl2 Inorganic materials 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 150000001502 aryl halides Chemical class 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 150000005347 biaryls Chemical class 0.000 description 2
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 2
- 150000001649 bromium compounds Chemical class 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 150000004795 grignard reagents Chemical class 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 150000002390 heteroarenes Chemical class 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 238000012988 high-throughput synthesis Methods 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 150000004694 iodide salts Chemical class 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- HZVOZRGWRWCICA-UHFFFAOYSA-N methanediyl Chemical class [CH2] HZVOZRGWRWCICA-UHFFFAOYSA-N 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000003541 multi-stage reaction Methods 0.000 description 2
- 125000002734 organomagnesium group Chemical group 0.000 description 2
- 238000006464 oxidative addition reaction Methods 0.000 description 2
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 125000002577 pseudohalo group Chemical group 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- BGHCVCJVXZWKCC-UHFFFAOYSA-N tetradecane Chemical compound CCCCCCCCCCCCCC BGHCVCJVXZWKCC-UHFFFAOYSA-N 0.000 description 2
- 125000005490 tosylate group Chemical group 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- 230000007306 turnover Effects 0.000 description 2
- 238000010626 work up procedure Methods 0.000 description 2
- 239000011592 zinc chloride Substances 0.000 description 2
- 235000005074 zinc chloride Nutrition 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- ABJSOROVZZKJGI-OCYUSGCXSA-N (1r,2r,4r)-2-(4-bromophenyl)-n-[(4-chlorophenyl)-(2-fluoropyridin-4-yl)methyl]-4-morpholin-4-ylcyclohexane-1-carboxamide Chemical compound C1=NC(F)=CC(C(NC(=O)[C@H]2[C@@H](C[C@@H](CC2)N2CCOCC2)C=2C=CC(Br)=CC=2)C=2C=CC(Cl)=CC=2)=C1 ABJSOROVZZKJGI-OCYUSGCXSA-N 0.000 description 1
- QPKCDMXLSDFCQD-JTQLQIEISA-N (6s)-8-bromo-2,6-dimethyloct-2-ene Chemical compound BrCC[C@@H](C)CCC=C(C)C QPKCDMXLSDFCQD-JTQLQIEISA-N 0.000 description 1
- IBSQPLPBRSHTTG-UHFFFAOYSA-N 1-chloro-2-methylbenzene Chemical compound CC1=CC=CC=C1Cl IBSQPLPBRSHTTG-UHFFFAOYSA-N 0.000 description 1
- HJNBCVWWPLRZLC-UHFFFAOYSA-N 1-methylpyrrolidin-2-one;oxolane Chemical compound C1CCOC1.CN1CCCC1=O HJNBCVWWPLRZLC-UHFFFAOYSA-N 0.000 description 1
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 1
- WKBALTUBRZPIPZ-UHFFFAOYSA-N 2,6-di(propan-2-yl)aniline Chemical compound CC(C)C1=CC=CC(C(C)C)=C1N WKBALTUBRZPIPZ-UHFFFAOYSA-N 0.000 description 1
- TVTJUIAKQFIXCE-HUKYDQBMSA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynyl-1H-purine-6,8-dione Chemical compound NC=1NC(C=2N(C(N(C=2N=1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C)=O TVTJUIAKQFIXCE-HUKYDQBMSA-N 0.000 description 1
- XMZQWZJMTBCUFT-UHFFFAOYSA-N 3-bromopropylbenzene Chemical compound BrCCCC1=CC=CC=C1 XMZQWZJMTBCUFT-UHFFFAOYSA-N 0.000 description 1
- XZBXAYCCBFTQHH-UHFFFAOYSA-N 3-chloropropylbenzene Chemical compound ClCCCC1=CC=CC=C1 XZBXAYCCBFTQHH-UHFFFAOYSA-N 0.000 description 1
- FHQRDEDZJIFJAL-UHFFFAOYSA-N 4-phenylmorpholine Chemical compound C1COCCN1C1=CC=CC=C1 FHQRDEDZJIFJAL-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229940126639 Compound 33 Drugs 0.000 description 1
- 102100035861 Cytosolic 5'-nucleotidase 1A Human genes 0.000 description 1
- 238000004057 DFT-B3LYP calculation Methods 0.000 description 1
- 238000003775 Density Functional Theory Methods 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 101000802744 Homo sapiens Cytosolic 5'-nucleotidase 1A Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- 241000357437 Mola Species 0.000 description 1
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 description 1
- NFHFRUOZVGFOOS-UHFFFAOYSA-N Pd(PPh3)4 Substances [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 1
- 229910019032 PtCl2 Inorganic materials 0.000 description 1
- PNUZDKCDAWUEGK-CYZMBNFOSA-N Sitafloxacin Chemical compound C([C@H]1N)N(C=2C(=C3C(C(C(C(O)=O)=CN3[C@H]3[C@H](C3)F)=O)=CC=2F)Cl)CC11CC1 PNUZDKCDAWUEGK-CYZMBNFOSA-N 0.000 description 1
- 239000003875 Wang resin Substances 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- NERFNHBZJXXFGY-UHFFFAOYSA-N [4-[(4-methylphenyl)methoxy]phenyl]methanol Chemical compound C1=CC(C)=CC=C1COC1=CC=C(CO)C=C1 NERFNHBZJXXFGY-UHFFFAOYSA-N 0.000 description 1
- VXDZQIGAXDFZGH-UHFFFAOYSA-M [Br-].CCCCCCC[Zn+] Chemical compound [Br-].CCCCCCC[Zn+] VXDZQIGAXDFZGH-UHFFFAOYSA-M 0.000 description 1
- KTBWGGGOIAPZLA-UHFFFAOYSA-M [Cl-].CC(C)C1=CC(C(C)C)=C([Zn+])C(C(C)C)=C1 Chemical compound [Cl-].CC(C)C1=CC(C(C)C)=C([Zn+])C(C(C)C)=C1 KTBWGGGOIAPZLA-UHFFFAOYSA-M 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001263 acyl chlorides Chemical class 0.000 description 1
- 150000001348 alkyl chlorides Chemical class 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 239000012036 alkyl zinc reagent Substances 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 125000001204 arachidyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000001499 aryl bromides Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- IPWKHHSGDUIRAH-UHFFFAOYSA-N bis(pinacolato)diboron Chemical compound O1C(C)(C)C(C)(C)OB1B1OC(C)(C)C(C)(C)O1 IPWKHHSGDUIRAH-UHFFFAOYSA-N 0.000 description 1
- 229910000085 borane Inorganic materials 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 125000005620 boronic acid group Chemical class 0.000 description 1
- 239000001405 butyl (E)-3-phenylprop-2-enoate Substances 0.000 description 1
- OHHIVLJVBNCSHV-KTKRTIGZSA-N butyl cinnamate Chemical compound CCCCOC(=O)\C=C/C1=CC=CC=C1 OHHIVLJVBNCSHV-KTKRTIGZSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000005829 chemical entities Chemical class 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000006757 chemical reactions by type Methods 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229940126086 compound 21 Drugs 0.000 description 1
- 229940125851 compound 27 Drugs 0.000 description 1
- 238000005112 continuous flow technique Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000006547 cyclononyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 150000001942 cyclopropanes Chemical class 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 230000006324 decarbonylation Effects 0.000 description 1
- 238000006606 decarbonylation reaction Methods 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- ZHXTWWCDMUWMDI-UHFFFAOYSA-N dihydroxyboron Chemical compound O[B]O ZHXTWWCDMUWMDI-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- YCOZIPAWZNQLMR-UHFFFAOYSA-N heptane - octane Natural products CCCCCCCCCCCCCCC YCOZIPAWZNQLMR-UHFFFAOYSA-N 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000007172 homogeneous catalysis Methods 0.000 description 1
- JCYWCSGERIELPG-UHFFFAOYSA-N imes Chemical compound CC1=CC(C)=CC(C)=C1N1C=CN(C=2C(=CC(C)=CC=2C)C)[C]1 JCYWCSGERIELPG-UHFFFAOYSA-N 0.000 description 1
- 150000004693 imidazolium salts Chemical class 0.000 description 1
- 238000010952 in-situ formation Methods 0.000 description 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 239000003317 industrial substance Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- MZRVEZGGRBJDDB-UHFFFAOYSA-N n-Butyllithium Substances [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 150000002826 nitrites Chemical class 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- IOQPZZOEVPZRBK-UHFFFAOYSA-N octan-1-amine Chemical compound CCCCCCCCN IOQPZZOEVPZRBK-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000004045 organic chlorine compounds Chemical class 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- WXHIJDCHNDBCNY-UHFFFAOYSA-N palladium dihydride Chemical compound [PdH2] WXHIJDCHNDBCNY-UHFFFAOYSA-N 0.000 description 1
- MUJIDPITZJWBSW-UHFFFAOYSA-N palladium(2+) Chemical class [Pd+2] MUJIDPITZJWBSW-UHFFFAOYSA-N 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 239000002952 polymeric resin Substances 0.000 description 1
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 1
- CASUWPDYGGAUQV-UHFFFAOYSA-M potassium;methanol;hydroxide Chemical compound [OH-].[K+].OC CASUWPDYGGAUQV-UHFFFAOYSA-M 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 238000010532 solid phase synthesis reaction Methods 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- CMHHITPYCHHOGT-UHFFFAOYSA-N tributylborane Chemical compound CCCCB(CCCC)CCCC CMHHITPYCHHOGT-UHFFFAOYSA-N 0.000 description 1
- RXJKFRMDXUJTEX-UHFFFAOYSA-N triethylphosphine Chemical compound CCP(CC)CC RXJKFRMDXUJTEX-UHFFFAOYSA-N 0.000 description 1
- 150000008648 triflates Chemical class 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
Landscapes
- Catalysts (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The present invention relates to catalysts of transition metal complexes of N-heterocyclic carbenes, their methods of preparation and their use in chemical synthesis. The synthesis, ease-of-use, and activity of the compounds of the present invention are substantial improvements over in situ catalyst generation. Further, the transition metal complexes of N-heterocyclic carbenes of the present invention may be used as precatalysts in metal-catalyzed cross-coupling reactions.
Description
B&P File No. 14907-5 TITLE: TRANSITION METAL COMPLEXES OF N-HETEROCYCLIC
CARBENES, METHOD OF PREPARATION AND USE IN TRANSITION
METAL CATALYZED ORGANIC TRANSFORMATIONS
FIELD OF THE INVENTION
The present invention relates to catalysts for chemical synthesis, particularly catalysts of transition metal complexes of N-heterocyclic carbenes, their methods of preparation and their use in chemical synthesis.
BACKGROUND OF THE INVENTION
The formation of C-X bonds, where X is for example C, S, N, B, O, Sn and Si, is crucial in chemical synthesis and some of the most powerful methodologies to create these bonds are cross-coupling reactions. Over the last thirty years, the development of transition metal catalyzed cross-coupling reactions has transformed the way these bonds are created (Metal-Catalyzed Cross-Coupling Reactions, 2 ed. [Eds.: A. de Meijere, F. Diederich), Wiley VCH, Weinheim, (2004); Handbook of Organopalladium Chemistry for Organic Synthesis, ed. (Ed.: E. Negishi), John Wiley & Sons, New York, (2002)] .
Within the current arsenal of transition metal catalyzed cross-coupling protocols, palladium processes are amongst the most widely employed and include Hiyama [Y. Hatanaka, T. Hiyama, J. Org. Chem. (1988), 53, 918], Kumada [K. Tamao, K. Sumitani, M. Kumada, J. Am. Chem. Soc. (1972), 94, 4374], Negishi [E. Negishi, A. O. King, N. Okukado, J. Org. Chem. (1977), 42, 1821; A. O. King, N. Okukado, E. Negishi, Chem. Commun. (1977), 683], Suzuki [N. Miyaura, K. Yamada, A. Suzuki, Tetrahedron Lett. (1979), 20, 3437] and Stille [D. Milstein, J. K. Stille, J. Am. Chem. Soc. (1978), 100, 3636) reactions. In spite of tremendous progress in the developments of general methods to couple aryl and alkenyl halides, the use of alkyl halides remained a longstanding challenge, until the advent of bulky, electron rich phosphine ligands. In fact, central to the success of these transformations are palladium metal centers ligated most often with tertiary phosphines or, recently N
heterocyclic carbenes. Unfortunately, phosphines are air sensitive and some even pyrophoric. Furthermore, because active palladium (0) complexes are unstable and normally decompose with time, most protocols involve in situ formation of the catalyst.
Although yearly improvements to the supporting ligands have been made [A. Zapf, M. Beller, Chem. Commun. (2005), 431; T. E. Barder, S. D.
Walker, J. R. Martinelli, S. L. Buchwald, J. Am. Chem. Soc. (2005), 127, 4685;
C. J. O'Brien, E. A. B. Kantchev, G. A. Chass, N. Hadei, A. C. Hopkinson, M.
G. Organ, D. H. Setiadi, T.-H. Tang, D.-C. Fang, Tetrahedron (2005), 61, 9723; J. E. Milne, S. L. Buchwald, J. Am. Chem. Soc. (2004), 126, 13028; T.
Brenstrum, D. A. Gerristma, G. M. Adjabeng, C. S. Frampton, J. Britten, A. J.
Robertson, J. McNulty, A. Capretta, J. Org. Chem. (2004), 69, 7635; T.
Brenstrum, D. A. Gerristma, G. M. Adjabeng, C. S. Frampton, J. Britten, A. J.
Robertson, J. McNulty, A. Capretta, J. Org. Chem. (2004), 69, 7635; J. H.
Kirchhoff, C. Dai, G. C. Fu, Angew. Chem. (2002), 114, 2025; Angew. Chem.
Int. Ed. (2002), 41, 1945; M. R. Netherton, G. C. Fu, Angew. Chem. (2002), 114, 4066; Angew. Chem. Int. Ed. (2002), 41, 3910; G. A. Grasa, M. S. Viciu, J. Huang, C. Zhang, M. L. Trudell, S. P. Nolan, Organometallics (2002), 21, 2866; M. R. Netherton, C. Dai, K. Neuschiitz, G. C. Fu, J. Am. Chem. Soc.
(2001 ), 123, 10099], advanced ligands [A. C. Frisch, M. Beller, Angew. Chem.
(2005), 117, 680; Angew. Chem. Int. Ed. (2005), 44, 674] are still under-used mainly due to sensitivity, difficulty-of use, limited availability and expense.
Indeed, most synthetic chemists still rely on the reasonably versatile Pd(PPh3)4, first synthesized by Malatesta and Angoletta in 1957 [L. Malatesta, M. Angoletta, J. Chem. Soc. (1957), 1186].
As mentioned above, recently, an alternative to the "tried and tested"
phosphine ligands has emerged. N-Heterocyclic carbenes (NHC) have attracted considerable interest as ligands for transition metal homogeneous catalysis. Due to their excellent a-donor properties and their variable steric bulk, NHC ligands impart excellent activity and thermal stability to the catalysts formed. The groups of Beller [R. Jackstell, M. G. Andreu, A. C.
CARBENES, METHOD OF PREPARATION AND USE IN TRANSITION
METAL CATALYZED ORGANIC TRANSFORMATIONS
FIELD OF THE INVENTION
The present invention relates to catalysts for chemical synthesis, particularly catalysts of transition metal complexes of N-heterocyclic carbenes, their methods of preparation and their use in chemical synthesis.
BACKGROUND OF THE INVENTION
The formation of C-X bonds, where X is for example C, S, N, B, O, Sn and Si, is crucial in chemical synthesis and some of the most powerful methodologies to create these bonds are cross-coupling reactions. Over the last thirty years, the development of transition metal catalyzed cross-coupling reactions has transformed the way these bonds are created (Metal-Catalyzed Cross-Coupling Reactions, 2 ed. [Eds.: A. de Meijere, F. Diederich), Wiley VCH, Weinheim, (2004); Handbook of Organopalladium Chemistry for Organic Synthesis, ed. (Ed.: E. Negishi), John Wiley & Sons, New York, (2002)] .
Within the current arsenal of transition metal catalyzed cross-coupling protocols, palladium processes are amongst the most widely employed and include Hiyama [Y. Hatanaka, T. Hiyama, J. Org. Chem. (1988), 53, 918], Kumada [K. Tamao, K. Sumitani, M. Kumada, J. Am. Chem. Soc. (1972), 94, 4374], Negishi [E. Negishi, A. O. King, N. Okukado, J. Org. Chem. (1977), 42, 1821; A. O. King, N. Okukado, E. Negishi, Chem. Commun. (1977), 683], Suzuki [N. Miyaura, K. Yamada, A. Suzuki, Tetrahedron Lett. (1979), 20, 3437] and Stille [D. Milstein, J. K. Stille, J. Am. Chem. Soc. (1978), 100, 3636) reactions. In spite of tremendous progress in the developments of general methods to couple aryl and alkenyl halides, the use of alkyl halides remained a longstanding challenge, until the advent of bulky, electron rich phosphine ligands. In fact, central to the success of these transformations are palladium metal centers ligated most often with tertiary phosphines or, recently N
heterocyclic carbenes. Unfortunately, phosphines are air sensitive and some even pyrophoric. Furthermore, because active palladium (0) complexes are unstable and normally decompose with time, most protocols involve in situ formation of the catalyst.
Although yearly improvements to the supporting ligands have been made [A. Zapf, M. Beller, Chem. Commun. (2005), 431; T. E. Barder, S. D.
Walker, J. R. Martinelli, S. L. Buchwald, J. Am. Chem. Soc. (2005), 127, 4685;
C. J. O'Brien, E. A. B. Kantchev, G. A. Chass, N. Hadei, A. C. Hopkinson, M.
G. Organ, D. H. Setiadi, T.-H. Tang, D.-C. Fang, Tetrahedron (2005), 61, 9723; J. E. Milne, S. L. Buchwald, J. Am. Chem. Soc. (2004), 126, 13028; T.
Brenstrum, D. A. Gerristma, G. M. Adjabeng, C. S. Frampton, J. Britten, A. J.
Robertson, J. McNulty, A. Capretta, J. Org. Chem. (2004), 69, 7635; T.
Brenstrum, D. A. Gerristma, G. M. Adjabeng, C. S. Frampton, J. Britten, A. J.
Robertson, J. McNulty, A. Capretta, J. Org. Chem. (2004), 69, 7635; J. H.
Kirchhoff, C. Dai, G. C. Fu, Angew. Chem. (2002), 114, 2025; Angew. Chem.
Int. Ed. (2002), 41, 1945; M. R. Netherton, G. C. Fu, Angew. Chem. (2002), 114, 4066; Angew. Chem. Int. Ed. (2002), 41, 3910; G. A. Grasa, M. S. Viciu, J. Huang, C. Zhang, M. L. Trudell, S. P. Nolan, Organometallics (2002), 21, 2866; M. R. Netherton, C. Dai, K. Neuschiitz, G. C. Fu, J. Am. Chem. Soc.
(2001 ), 123, 10099], advanced ligands [A. C. Frisch, M. Beller, Angew. Chem.
(2005), 117, 680; Angew. Chem. Int. Ed. (2005), 44, 674] are still under-used mainly due to sensitivity, difficulty-of use, limited availability and expense.
Indeed, most synthetic chemists still rely on the reasonably versatile Pd(PPh3)4, first synthesized by Malatesta and Angoletta in 1957 [L. Malatesta, M. Angoletta, J. Chem. Soc. (1957), 1186].
As mentioned above, recently, an alternative to the "tried and tested"
phosphine ligands has emerged. N-Heterocyclic carbenes (NHC) have attracted considerable interest as ligands for transition metal homogeneous catalysis. Due to their excellent a-donor properties and their variable steric bulk, NHC ligands impart excellent activity and thermal stability to the catalysts formed. The groups of Beller [R. Jackstell, M. G. Andreu, A. C.
Frisch, K. Selvakumar, A. Zapf, H. Klein, A. Spannenberg, D. Rottger, O.
Briel, R. Karch, M. Beller, Angew. Chem. (2002), 114, 1028; Angew. Chem.
Int. Ed. (2002), 41, 986; A. C. Frisch, F. Rataboul, A. Zapf, M. Beller, J.
Organomet. Chem. (2003), 687, 403], Herrmann [G. D. Frey, J. Schutz, E.
Herdtweck, W. A. Herrmann, Organometallics (2005), 24, 4416; C. W. K.
Gstottmayr, V. P. W. Bohm, E. Herdtweck, M. Grosche, W. A. Herrmann, Angew. Chem. (2002), 114, 1421; Angew. Chem. Int. Ed. (2002), 41, 1363;
W. A. Herrmann, C.-P. Reisinger, M. Spiegler, J. Organomet. Chem. (1998), 557, 93], Nolan [O. Navarro, N. Marion, N. M. Scott, J. Gonzalez, D. Amoroso, A. Bell, S. P. Nolan, Tetrahedron (2005), 61, 9716; R. Singh, M. S. Viciu, N.
Kramareva, O. Navarro, S. P. Nolan, Org. Lett. (2005), 7, 1829; H. Lebel, M.
K. Janes, A. B. Charette, S. P. Nolan, J. Am. Chem. Soc. (2004), 126, 5046;
M. S. Viciu, E. D. Stevens, J. L. Petersen, S. P. Nolan, Organometallics (2004), 23, 3752; M. S. Viciu, O. Navarro, R. F. Germaneau, R. A. Kelly III, W.
Sommer, N. Marion, E. D. Stevens, C. Luigi, S. P. Nolan, Organometallics (2004), 23, 1629; M. S. Viciu, R. A. Kelly, E. D. Stevens, F. Naud, M. Studer, S. P. Nolan, Org. Lett. (2003), 5, 1479] and Sigman [D. R. Jensen, M. J.
Schultz, J. A. Mueller, M. S. Sigman, Angew. Chem. (2003), 115, 3940;
Angew. Chem. Int. Ed. (2003), 42, 3810] have made significant progress towards the development NHC-based palladium catalysts. However, when compared to processes utilizing phosphine ligands, the development of NHC-based protocols has been less successful. Indeed, palladium-NHC catalysts lack the substrate scope and ease-of-use of their phosphine cousins [Peris, E.; Crabtree, R. H. Coord. Chem. Rev. (2004), 248, 2239-2246; Crudden, C.
M.; Allen, D. P. Coord. Chem. Rev. (2004), 248, 2247-2273; Herrmann, W. A.;
bfele, K.; v. Preysing, D.; Schneider, K. S. J. Organomet. Chem. (2003), 687, 229-248; Herrmann, W. A. Angew. Chem., Int. Ed. (2002), 41, 1290-1309].
The high sensitivity of isolated N-heterocyclic carbenes necessitates handling under rigorously anhydrous conditions, typically employing a glove-box.
These factors make large scale production using these catalysts unattractive [Arentsen, K.; Caddick, S.; Cloke, F. G. N.; Herring, A. P.; Hitchcock, P. B.
Tetrahedron Lett. (2004), 45, 3511-3515; Hadei, N.; Kantchev, E. A. B.;
Briel, R. Karch, M. Beller, Angew. Chem. (2002), 114, 1028; Angew. Chem.
Int. Ed. (2002), 41, 986; A. C. Frisch, F. Rataboul, A. Zapf, M. Beller, J.
Organomet. Chem. (2003), 687, 403], Herrmann [G. D. Frey, J. Schutz, E.
Herdtweck, W. A. Herrmann, Organometallics (2005), 24, 4416; C. W. K.
Gstottmayr, V. P. W. Bohm, E. Herdtweck, M. Grosche, W. A. Herrmann, Angew. Chem. (2002), 114, 1421; Angew. Chem. Int. Ed. (2002), 41, 1363;
W. A. Herrmann, C.-P. Reisinger, M. Spiegler, J. Organomet. Chem. (1998), 557, 93], Nolan [O. Navarro, N. Marion, N. M. Scott, J. Gonzalez, D. Amoroso, A. Bell, S. P. Nolan, Tetrahedron (2005), 61, 9716; R. Singh, M. S. Viciu, N.
Kramareva, O. Navarro, S. P. Nolan, Org. Lett. (2005), 7, 1829; H. Lebel, M.
K. Janes, A. B. Charette, S. P. Nolan, J. Am. Chem. Soc. (2004), 126, 5046;
M. S. Viciu, E. D. Stevens, J. L. Petersen, S. P. Nolan, Organometallics (2004), 23, 3752; M. S. Viciu, O. Navarro, R. F. Germaneau, R. A. Kelly III, W.
Sommer, N. Marion, E. D. Stevens, C. Luigi, S. P. Nolan, Organometallics (2004), 23, 1629; M. S. Viciu, R. A. Kelly, E. D. Stevens, F. Naud, M. Studer, S. P. Nolan, Org. Lett. (2003), 5, 1479] and Sigman [D. R. Jensen, M. J.
Schultz, J. A. Mueller, M. S. Sigman, Angew. Chem. (2003), 115, 3940;
Angew. Chem. Int. Ed. (2003), 42, 3810] have made significant progress towards the development NHC-based palladium catalysts. However, when compared to processes utilizing phosphine ligands, the development of NHC-based protocols has been less successful. Indeed, palladium-NHC catalysts lack the substrate scope and ease-of-use of their phosphine cousins [Peris, E.; Crabtree, R. H. Coord. Chem. Rev. (2004), 248, 2239-2246; Crudden, C.
M.; Allen, D. P. Coord. Chem. Rev. (2004), 248, 2247-2273; Herrmann, W. A.;
bfele, K.; v. Preysing, D.; Schneider, K. S. J. Organomet. Chem. (2003), 687, 229-248; Herrmann, W. A. Angew. Chem., Int. Ed. (2002), 41, 1290-1309].
The high sensitivity of isolated N-heterocyclic carbenes necessitates handling under rigorously anhydrous conditions, typically employing a glove-box.
These factors make large scale production using these catalysts unattractive [Arentsen, K.; Caddick, S.; Cloke, F. G. N.; Herring, A. P.; Hitchcock, P. B.
Tetrahedron Lett. (2004), 45, 3511-3515; Hadei, N.; Kantchev, E. A. B.;
O'Brien, C. J.; Organ, M. G. Org. Lett. (2005), 7, 1991-1994; Arentsen, K.;
Caddick, S.; Cloke, F. G. N. Tetrahedron (2005), 61, 9710-9715; Grasa, G. A.;
Viciu, M. S.; Huang, J.; Zhang, C.; Trudell, M. L.; Nolan, S. P.
Organometallics (2002), 21, 2866-2873]. In situ preparation of active Pd-NHC
catalysts has been the dominant strategy to overcome these problems, however such strategies have been plagued with irreproducibility and wide yield variations [O'Brien, C. J.; Kantchev, E. A. B.; Chass, G. A.; Hadei, N.;
Hopkinson, A. C.; Organ, M. G.; Setiadi, D. H.; Tang, T.-H.; Fang, D.-C.
Tetrahedron (2005), 61, 9723-9735].
Palladium (II) complexes of N-ferrocenyl-substituted N-heterocyclic carbenes have been reported [Bertogg, A.; Camponovo. F.; Togni, A. Eur. J.
Inorg. Chem. (2005), 347-356]. In this publication, an intermediate Pd~~
species comprising a pyridine ligand was prepared, however due to its instability and the formation of dimeric species, this compound was converted to a complex containing a triphenylphosphine ligand and this complex was used in catalytic asymmetric amide cyclizations.
There is therefore a need for air-stable, easy-to-prepare-and-handle transition metal-heterocyclic carbene complexes that are readily activated under the reaction conditions for use in routine and industrial chemical synthesis.
SUMMARY OF THE INVENTION
An air and moisture stable N-heterocyclic carbene-Pd(II) precatalyst that generates a monoligated N-heterocyclic carbene-Pd(0) complex in situ has been prepared and shown to be an effective reagent in a variety of cross coupling reactions. Said precatalyst comprises a metal species bearing one N-heterocyclic carbene ligand, one or more anionic ligands (depending on the charge of the metal) and a cooperative or throw-away ligand.
Accordingly, the present invention is directed to transition metal complexes of N-heterocyclic carbenes as precatalysts, their methods of preparation and their use in chemical synthesis.
In an embodiment, the present invention relates to a compound of the formula I:
~a MXb L
Caddick, S.; Cloke, F. G. N. Tetrahedron (2005), 61, 9710-9715; Grasa, G. A.;
Viciu, M. S.; Huang, J.; Zhang, C.; Trudell, M. L.; Nolan, S. P.
Organometallics (2002), 21, 2866-2873]. In situ preparation of active Pd-NHC
catalysts has been the dominant strategy to overcome these problems, however such strategies have been plagued with irreproducibility and wide yield variations [O'Brien, C. J.; Kantchev, E. A. B.; Chass, G. A.; Hadei, N.;
Hopkinson, A. C.; Organ, M. G.; Setiadi, D. H.; Tang, T.-H.; Fang, D.-C.
Tetrahedron (2005), 61, 9723-9735].
Palladium (II) complexes of N-ferrocenyl-substituted N-heterocyclic carbenes have been reported [Bertogg, A.; Camponovo. F.; Togni, A. Eur. J.
Inorg. Chem. (2005), 347-356]. In this publication, an intermediate Pd~~
species comprising a pyridine ligand was prepared, however due to its instability and the formation of dimeric species, this compound was converted to a complex containing a triphenylphosphine ligand and this complex was used in catalytic asymmetric amide cyclizations.
There is therefore a need for air-stable, easy-to-prepare-and-handle transition metal-heterocyclic carbene complexes that are readily activated under the reaction conditions for use in routine and industrial chemical synthesis.
SUMMARY OF THE INVENTION
An air and moisture stable N-heterocyclic carbene-Pd(II) precatalyst that generates a monoligated N-heterocyclic carbene-Pd(0) complex in situ has been prepared and shown to be an effective reagent in a variety of cross coupling reactions. Said precatalyst comprises a metal species bearing one N-heterocyclic carbene ligand, one or more anionic ligands (depending on the charge of the metal) and a cooperative or throw-away ligand.
Accordingly, the present invention is directed to transition metal complexes of N-heterocyclic carbenes as precatalysts, their methods of preparation and their use in chemical synthesis.
In an embodiment, the present invention relates to a compound of the formula I:
~a MXb L
5 wherein R' and R2 are independently or simultaneously selected from the group consisting of C~_ZOalkyl, C3_2ocycloalkyl, aryl and heteroaryl, said latter 4 groups being optionally substituted and/or one or more of the CH2 groups in C~_ZOalkyl and/or C3_2ocycloalkyl is optionally replaced with a heteroatom selected from the group consisting of O, S, and NRS;
R3 and R4 are independently or simultaneously selected from the group consisting of H, halo, C~_2oalkyl, OC~_2oalkyl, C3_2ocycloalkyl, OC3_ZOCycloalkyl aryl, O-aryl, heteroaryl and O-heteroaryl, said latter 8 groups being optionally substituted and/or one or more of the CH2 groups in C~_2oalkyl, OC~_2oalkyl, C3_ 2ocycloalkyl and/or OC3_2ocycloalkyl is optionally replaced with a heteroatom selected from the group consisting of O, S, and NRS;
or R3 and R4 are linked to form an optionally substituted 4 to 12-membered ring system which optionally contains one or more heteroatoms selected from the group consisting of O, S, and NR5;
R5 is selected from the group consisting of H and C~_salkyl;
-- is a single or a double bond;
ais1,2or3;
M is a transition metal;
b is an integer representing the number of the anionic ligands X required to fulfill the valency requirements of M;
X is an anionic ligand and when b is greater than 1, each X may be the same or different;
R3 and R4 are independently or simultaneously selected from the group consisting of H, halo, C~_2oalkyl, OC~_2oalkyl, C3_2ocycloalkyl, OC3_ZOCycloalkyl aryl, O-aryl, heteroaryl and O-heteroaryl, said latter 8 groups being optionally substituted and/or one or more of the CH2 groups in C~_2oalkyl, OC~_2oalkyl, C3_ 2ocycloalkyl and/or OC3_2ocycloalkyl is optionally replaced with a heteroatom selected from the group consisting of O, S, and NRS;
or R3 and R4 are linked to form an optionally substituted 4 to 12-membered ring system which optionally contains one or more heteroatoms selected from the group consisting of O, S, and NR5;
R5 is selected from the group consisting of H and C~_salkyl;
-- is a single or a double bond;
ais1,2or3;
M is a transition metal;
b is an integer representing the number of the anionic ligands X required to fulfill the valency requirements of M;
X is an anionic ligand and when b is greater than 1, each X may be the same or different;
L is a 5- to 6-membered optionally substituted N-containing aromatic heterocycle coordinated to M through N, which is optionally benzofused, and/or optionally contains one or more other heteroatoms selected from the group consisting of O, S, and NR5, and/or one or more of the optional substituents on the N-containing aromatic heterocycle is bonded to M in place of one or more X;
or L is R6-C=C-R' in which R' and R$ are independently or simultaneously selected from the group consisting of C~_2oalkyl, OC~_2oalkyl, C3_2ocycloalkyl, OC3_ZOCycloalkyl, aryl, O-aryl, heteroaryl and O-heteroaryl, said latter 8 groups being optionally substituted;
one or more of the carbons of the alkyl and cycloalkyl groups of R6 and R' are optionally replaced with -C(O)-, -C(O)NR5- and -C(O)O-;
aryl is an optionally substituted mono- or polycyclic aromatic radical containing from 6 to 14 carbon atoms;
heteroaryl is a mono- or polycyclic heteroaromatic radical containing from 5 to 14 atoms, of which 1 to 5 atoms may be a heteroatom selected from the group consisting of S, O, N and NRS; and optionally substituted means that one or more of the hydrogens on the group are optionally replaced with halo, OH, C~_salkyl, OC~_salkyl, fluoro-substituted C~_salkyl, fluoro-substituted OC~_6alkyl, aryl or aryl that is substituted with 1-5 substituents independently or simultaneously selected from the group consisting of fluoro, C,_4alkyl, OC,_aalkyl, fluoro-substituted C,_4alkyl and fluoro-substituted OC~_4alkyl.
The present invention further relates to a method of preparing a compound of formula I wherein X is halo, in particular CI or Br, the method comprising:
combining a salt of an N-heterocyclic carbene, a ligand L and a metal salt MXb in the presence of a base to form a reaction mixture; and separating the compound of formula I formed in the reaction mixture;
wherein the N-heterocyclic carbene is R3 Ra a R1_Nm~ _R2 a Yo and R' to R4, M, L and a are defined as above and Y is any suitable anion. It is an embodiment of the present invention that when L is a liquid, no solvent is required for the preparation of compounds of formula I.
Also within the scope of the present invention is a method for performing a metal-catalyzed cross-coupling reaction comprising: contacting suitable cross-coupling substrates with a compound of formula I, under conditions for the formation of cross-coupling product, to form a reaction mixture; and, optionally separating the cross-coupling product from the reaction mixture; wherein the compound of formula I is converted to an active catalyst under suitable reaction conditions in the reaction mixture.
It is an embodiment of the present invention that the ligand "L" is a "cooperative" or "throw-away" ligand which aids or improves the performance of the precatalysts of formula I and/or the corresponding Pd(0) catalyst formed from the formula I compounds. For example, L may act to stabilize the catalyst and/or enhance oxidative addition, transmetalation, reductive elimination and/or diastereo- and/or enantioselectivity during reactions catalyzed by these compounds.
The present invention therefore provides a NHC-Pd(II) precatalyst that can be prepared in large scale and stored with little or no deterioration in performance. Further, when the ligand L is a liquid in the NHC-Pd(II) precatalyst of the present invention, the synthesis of the precatalyst can be performed in solvent-less conditions. The NHC-I'd(II) precatalyst of the present invention can form a monoligated NHC-Pd(0) catalytic complex in situ and provides a clearly defined catalyst for use in subsequent coupling reactions. Another advantage of the present invention is that the activation of the catalyst at a desired temperature can be easily achieved by the choice of ligand L. Further, the performance of the catalyst can be easily altered or tuned by the cooperative ligands. Moreover, the NHC-Pd(0) catalyst generated from the NHC-Pd(II) precatalyst has been found to be an effective reagent in a variety of cross-coupling reactions.
For purposes of summarizing the invention and the advantages achieved over the prior art, certain objects and advantages of the invention have been described above. Of course, it is to be understood that not necessarily all such objects or advantages may be achieved in accordance with any particular embodiment of the invention. Thus, for example, those skilled in the art will recognize that the invention may be embodied or carried out in a manner that achieves or optimizes one advantage or group of advantages as taught herein without necessarily achieving other objects or advantages as may be taught or suggested herein.
Other features and advantages of the present invention will become apparent from the following detailed description. It should be understood, however, that the detailed description and the specific examples while indicating preferred embodiments of the invention are given by way of illustration only, since various changes and modifications within the spirit and scope of the invention will become apparent to those skilled in the art from this detailed description.
BRIEF DESCRIPTION OF THE DRAWINGS
The invention will now be described in relation to the drawings in which:
Figure 1 shows the rate studies with complexes Ih and Ij in the alkyl-alkyl cross-couplings: (a) Suzuki reaction; (b) Negishi reaction.
Figure 2 shows a proposed activation mechanism and use of complex Ih.
Figure 3 shows the rate studies with prior art in situ catalyst Pd2(dba)3/Ila and complex Ih in the alkyl-alkyl Negishi reaction: (a) rate comparison with Pd2(dba)3/Ila and complex Ih; (b) TON (turnover number) comparison between Pd2(dba)3/Ila and complex Ih after 1 hour.
Figure 4 shows a proposed mechanism for complex Ih catalyzed Negishi cross-coupling reactions.
DETAILED DESCRIPTION OF THE INVENTION
An array of novel Pd-N-heterocyclic carbene complexes have been prepared and shown to have superior properties in the generation of catalysts in transition metal cross-coupling reactions, in particular compared to catalysts generated in situ from corresponding imidazolium salt and a common Pd source (Pd2(dba)3).
Accordingly, the present invention includes a compound of the formula R3 Ra ~a R'-NYN-R2 MXb L
wherein R' and R2 are independently or simultaneously selected from the group consisting of C~_ZOalkyl, C3_2ocycloalkyl, aryl and heteroaryl, said latter 4 groups being optionally substituted and/or one or more of the CH2 groups in C~-2oalkyl and/or C3_ZOCycloalkyl is optionally replaced with a heteroatom selected from the group consisting of O, S, and NR5;
R3 and R4 are independently or simultaneously selected from the group consisting of H, halo, C~_2oalkyl, OC~_2oalkyl, Cs_2ocycloalkyl, OC3_2ocycloalkyl aryl, O-aryl, heteroaryl and O-heteroaryl, said latter 8 groups being optionally substituted and/or one or more of the CH2 groups in C~_2oalkyl, OCR-2oalkyl, C3_ 2ocycloalkyl and/or OCs_2ocycloalkyl is optionally replaced with a heteroatom selected from the group consisting of O, S, and NR5;
or R3 and R4 are linked to form an optionally substituted 4 to 12-membered ring system which optionally contains one or more heteroatoms selected from the group consisting of O, S, and NR5;
R5 is selected from the group consisting of H and C~_salkyl;
-- is a single or a double bond;
ais1,2or3;
M is a transition metal;
b is an integer representing the number of the anionic ligands X required to fulfill the valency requirements of M;
X is an anionic ligand and when b is greater than 1, each X may be the same or different;
5 L is a 5- to 6-membered optionally substituted N-containing aromatic heterocycle coordinated to M through N, which is optionally benzofused, and/or optionally contains one or more other heteroatoms selected from the group consisting of O, S, and NR5, and/or one or more of the optional substituents on the N-containing aromatic heterocycle is bonded to M in place 10 of one or more X;
or L is R6-C=C-R' in which R' and R$ are independently or simultaneously selected from the group consisting of C~_2oalkyl, OC~_2oalkyl, C3_2ocycloalkyl, OC3_2ocycloalkyl, aryl, O-aryl, heteroaryl and O-heteroaryl, said latter 8 groups being optionally substituted;
one or more of the carbons of the alkyl and cycloalkyl groups of R6 and R' are optionally replaced with -C(O)-, -C(O)NR5- and -C(O)O-;
aryl is an optionally substituted mono- or polycyclic aromatic radical containing from 6 to 14 carbon atoms;
heteroaryl is a mono- or polycyclic heteroaromatic radical containing from 5 to 14 atoms, of which 1 to 5 atoms may be a heteroatom selected from the group consisting of S, O, N and NRS; and optionally substituted means that one or more of the hydrogens on the group are optionally replaced with halo, OH, C~_salkyl, OC~_6alkyl, fluoro-substituted C~_6alkyl, fluoro-substituted OC,_6alkyl, aryl or aryl that is substituted with 1-5 substituents independently or simultaneously selected from the group consisting of fluoro, C~_4alkyl, OC~_4alkyl, fluoro-substituted C,_4alkyl and fluoro-substituted OC~_4alkyl.
The term "C~_ZOalkyl" as used herein means substituted or unsubstituted straight and/or branched chain alkyl groups containing from one to twenty carbon atoms and includes methyl, ethyl, propyl, isopropyl, t-butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, hexadecyl, octadecyl, icosyl and the like.
The term "C3_2ocycloalkyl" as used herein means saturated cyclic or polycyclic alkyl radicals containing from three to twenty carbon atoms and includes cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl, cyclodecyl, cycloundecyl, cyclododecyl, cyclohexadecyl, cyclooctadecyl, cycloicosyl, adamantyl and the like.
The term "aryl" as used herein means a substituted or unsubstituted monocyclic or polycyclic carbocyclic ring system containing one or two aromatic rings and from 6 to 14 carbon atoms and includes phenyl, naphthyl, anthraceneyl, 1,2-dihydronaphthyl, 1,2,3,4-tetrahydronaphthyl, fluorenyl, indanyl, indenyl and the like.
The term "heteroaryl" as used herein means unsubstituted or substituted mono- or polycyclic heteroaromatic radicals containing from 5 to 14 atoms, of which 1-3 atoms are a heteroatom selected from the group consisting of S, O, N and NR'2 where R~2 is H or C~_salkyl, and includes furanyl, thienyl, pyrrolo, pyridyl, indolo, benzofuranyl and the like.
The term "halo" as used herein means halogen and includes chloro, fluoro, bromo, iodo and the like.
The terms "fluoro-substituted C~_salkyl", "fluoro-substituted OC~_salkyl"
and "fluoro-substituted aryl" as used herein means that, in the alkyl or aryl portion of these groups, one or more, including all, of the hydrogen atoms are replaced with a fluorine atom.
The term "optionally substituted" as used herein, unless otherwise stated, means that one or more of the hydrogens on the group are optionally replaced with halo, OH, C~_salkyl, OC,-salkyl, fluoro-substituted C~_salkyl, fluoro-substituted OC~_salkyl, aryl or aryl that is substituted with 1-5 substituents independently or simultaneously selected from the group consisting of fluoro, C~_4alkyl, OC~_4alkyl, fluoro-substituted C~~alkyl and fluoro-substituted OC~_4alkyl.
The term "one or more" as used herein means that from one to the maximum allowable substitutions are allowed.
The present invention includes combinations of groups and substituents that are permitted and would provide a stable chemical entity according to standard chemical knowledge as would be known to those skilled in the art.
The term "polycyclic" or "ring system" as used herein means a cyclic group containing more than one ring in its structure, and includes bicyclic, tricyclic, bridged and spiro ring systems and the like.
It is an embodiment of the invention that the compounds of formula I
include those in which R' and R2 are independently or simultaneously C,_ ~oalkyl, C3_~6cYcloalkyl or aryl, wherein the latter three groups are optionally substituted. In an embodiment of the invention, R' and R2 are independently or simultaneously optionally substituted C3_~ocycloalkyl or optionally substituted aryl. In another embodiment of the invention, R' and R2 are independently or simultaneously optionally substituted C4_6cycloalkyl or optionally substituted phenyl. In an alternative embodiment of the invention, R' and R2 are independently or simultaneously optionally substituted cyclopropane, adamantyl or optionally substituted phenyl.
In an embodiment of the invention, R3 and R4 are independently or simultaneously H, or C~_~oalkyl, C3_~6cYcloalkyl or aryl, wherein the latter three groups are optionally substituted. In a further embodiment, R3 and R4 are independently or simultaneously H or optionally substituted C3_~ocycloalkyl or optionally substituted phenyl. In another embodiment of the invention, R3 and R4 are H. In a still further embodiment of the invention, R3 and R4 are linked to form an optionally substituted 6-membered ring system, such as phenyl.
It is also another embodiment of the invention that a is 1 or 2, specifically 1.
In an embodiment of the invention, M is selected from the group consisting of Fe, Ru, Os, Co, Rh, Ir, Ni, Pd and Pt. In another embodiment of the invention, M is selected from the group consisting of Fe, Ru, Rh, Ir, Pd and Pt. In a further embodiment of the invention, M is Pd, Rh, or Pt. In a still further embodiment of the invention, M is Pd or Pt, suitably Pd.
In an embodiment of the inventon, L is selected from the group consisting of pyridine, pyriazine, imidazole, quinoxaline and quinoline, all of which are optionally substituted. In an embodiment of the invention, the optional substituent is electron withdrawing in nature.
In a further embodiment of the invention, L is selected from the group consisting of Rs Nw R1° Rs N
R7 ~ , R9 and ~N
Ra R7 'Ra in which R6, R', Ra, R9 and R'° are independently or simultaneously selected from the group consisting of H, halo, OH, C~_6alkyl, OC,_salkyl, C3_~cylcloalkyl, OCs_7cycloalkyl, fluoro-substituted C~_6alkyl, fluoro-substituted OC~_salkyl, aryl or aryl that is substituted with 1-5 substituents independently or simultaneously selected from the group consisting of fluoro, C~_4alkyl, OC~_ 4alkyl, fluoro-substituted C~_4alkyl and fluoro-substituted OC~~alkyl. In a further embodiment of the invention, Rs, R', Ra, R9 and R'° are independently or simultaneously selected from the group consisting of H, halo, C,_~alkyl, C3_ scycloalkyl and aryl. In a still further embodiment of the invention, R6, R', Ra, R9 and R'° are independently or simultaneously selected from the group consisting of H, Br, CI, C~_fialkyl, fluoro-substituted C~_salkyl, C5_6cycloalkyl and phenyl. In a more particular embodiment of the invention, R6, R7, Ra, R9 and R'° are independently or simultaneously selected from the group consisting of H, CH3, CF3, Br, CI and phenyl. It is another embodiment of the invention that one or more R6, R', Ra, R9 and R'°, in particular R5 or R9, on the N-containing aromatic heterocycle is bonded to M in place of one or more X.
In an embodiment of the invention, L is Rs N Rio R~ ~ R9 Ra in which the embodiments for R6, R', R8, R9 and R'° are as defined above.
It is an embodiment of the present invention that the ligand "L" is a "cooperative" or "throw-away" ligand which aids or improves the performance of the precatalysts of formula I and/or the corresponding Pd(0) catalyst formed from the formula I compounds. For example, L may act to stabilize the catalyst and/or enhance oxidative addition, transmetalation, reductive elimination and/or diastereo- and/or enantioselectivity during reactions catalyzed by these compounds.
It is an embodiment of the invention that X is F, Br, CI, I or OC(O)CH3.
It is a more particular embodiment of the invention that X is CI or Br, suitably CI. It is a further embodiment of the invention that, when b is greater than one, each of X may be the same or different. For example, when b is 2, one X may be CI and the other may be Br, or they both may be CI or Br, suitably CI.
It is an embodiment of the invention that the optional substituents are selected from halo, C~_6alkyl, OC~_øalkyl, aryl and aryl that is substituted with 1-5 substituents independently or simultaneously selected from the group consisting of fluoro, G~_4alkyl, OC~_4alkyl, fluoro-substituted C,_4alkyl and fluoro-substituted OC~~alkyl. Further, it is an embodiment of the invention that the optional substituents are selected from F, methyl, ethyl, isopropyl, OCH3, CF3, OCF3, phenyl and phenyl that is substituted with 1-3 substituents, suitably 1-2 substituents, more suitably 1 substituent, independently or simultaneously selected from the group consisting of fluoro, methyl, OCH3, CF3 and OCF3.
In an embodiment of the invention, the compound of formula ! is selected from:
R R R ~ R R ~ R
\ N R ~ \ N N ~ ~ \ N N '~
Y 1 / R R ~ Y ~ / R
R M b ' / ' R MXb R ' MXb , L R L R L R
la Ib Ic R
R ~ R
NYN R ~ \ N N ~ R R
R MXb R ~ ~ ' R Xb R / / ~ Y ' /
R MXb R
L
Id 1e If R R
and N ~ N
MXb L
Ig in which R is H, methyl, ethyl, isopropyl, OCH3, CF3, OCF3 or F, and M, X, b, _ 5 --- and L are as defined above.
In another embodiment of the invention, the compound of formula I is selected from:
n / w N N \~ /% N N ~ % ~ N N
CI-~ CI
CI-Pd-CI N CI-Pd-CI
N ~ ~ ' N
v -CI
CI ~CI
Ih I~ IJ
/ j N N \ ~ ' N N
/i \
CI-~-CI
CI-Pd-CI i CI-Pd-Cf ,N and v 'CI
CI ~CI
Ik Im In In another embodiment of the invention, the compound of formula f is:
R3 Ra R1_ ~ _R2 X-M
N ~ I
to wherein R', R2, R3, R4, M, -~ and X are as defined in Formula I.
In yet another embodiment of the invention the compound of Formula I
is:
iPr iPr iPr iPr ~ I n ~ I ~ I n ~
N N ~ \ N N
iPr Y iPr ~r iPr Y iPr CI-M ~ CI-M
N ~. I N W I
Ip Iq In accordance with another of its aspects, the present invention includes a method of preparing the compounds of formula I, wherein X is CI or Br, comprising combining a salt of an N-heterocyclic carbene, a ligand L and a metal salt MXb in the presence of a base to form a reaction mixture; and separating the compounds of formula I formed in the reaction mixture, wherein the N-heterocyclic carbene is R3 Ra a R'-I~~ -R2 Ye and R' to R4, L, M, X, -- and b have the meanings provided above for Formula I and Y is any suitable counteranion, such as F-, CI-, Br , I- or PFs .
For example, compounds of the invention may be prepared, by the reaction sequence shown in Scheme 1:
a Ligand L a R'-NON-R2 + MXb R'-NYN-R2 Base Y~ MXb L
(II) (III) (I) Scheme 1 Accordingly, N-heterocyclic carbene salt of formula II in which R' to R4 and a are as defined in formula I, -- is a single or double bond (as appropriate) and Y is any suitable counteranion, may be reacted with transition metal complex of formula III in which M and b are as defined in formula I and X is CI or Br, in the presence of a base and ligand L as defined in formula I, and optionally, a solvent, to provide compounds of formula I by direct C-H insertion. A solvent may not be required when L is a liquid. Advantageously, the reaction may be performed without special precautions to exclude water or oxygen. For example, the reaction may be performed in air. Compounds of formula II, III
and L are either commercially available or may be prepared using methods known in the art. The anion Y may be any suitable anion, for example, F-, CI-, Br~, I-or PFs . The base may be any suitable base which is compatible with the compounds of formula II, III and L. One of ordinary skill in the art would know the appropriate bases which are suitable for use in the formation of compounds of formula I. For example, the base may be Cs2COs, K2C03, Na2COs, K3P03, CaC03 or NaOAc. Suitably, the base is Cs2C03, K2C03 or Na2C03. Compounds of formula II, III and L are suitably reacted in the presence of the base at a temperature of about 40°C to about 100°C. More suitably, the reaction mixture conducted at a temperature of about 60°C
to about 80°C. It has been shown that the reaction does provide optimal yields without the presence of a suitable base. In an embodiment of the invention, the base is present in excess amounts, for example, at least about 1.2 times, suitably at least about 5 times, the amount of the carbene and metal salts.
This contrasts with the method of Bertogg et al. [Bertogg, A.; Camponovo. F.;
Togni, A. Eur. J. Inorg. Chem. (2005), 347-356] which does not utilize an extra base, like the method of the present invention. The method described in Bertogg also results in the formation of undesirable dimeric side products which make up approximately 50°l0 of the yield from the reaction.
For compounds of Formula I, wherein X is other than CI or Br, the method of Bertogg [Bertogg, A.; Camponovo. F.; Togni, A. Eur. J. Inorg.
Chem. (2005), 347-356] or Marion et al. [Marion, N.; Ecarnot, E.C.; Navarro, O.; Amoroso, D.; Bell, A.; Nolan, S.P. J. Org. Chem. published on the web April 11, 2006, and references cited therein] may be utilized.
The isolation of the desired compound of the formula I is achieved using standard purification techniques. For example, the compound of formula I is separated from the reaction mixture by purification techniques selected from the group consisting of filtration, recrystallization, extraction, chromatography and combinations thereof.
Also within the scope of the present invention is a method for performing a metal-catalyzed cross-coupling reaction comprising: contacting suitable cross-coupling substrates with a compound of formula I, under conditions for the formation of cross-coupling product, to form a reaction mixture; and, optionally separating the cross-coupling product from the reaction mixture; wherein the compound of formula I is converted to an active catalyst under suitable reaction conditions in the reaction mixture.
Typically, suitable reaction conditions include the use of a suitable base, solvent and reaction temperatures as would be well known to those skilled in the art.
The present invention further includes a use of the compounds of formula I in metal catalyzed cross-coupling reactions. The invention also includes a use of the compounds of formula I as a pre-catalyst in a metal-catalyzed cross-coupling reaction.
In an embodiment of the invention, the cross-coupling reaction is for example, but not limited to, a Negishi coupling reaction, a Heck coupling reaction, a Suzuki coupling reaction, a Hiyama coupling reaction, a Sonogashira coupling reaction, a Stille coupling reaction, a Kumada coupling reaction, a Buchwald-Hartwig amination reaction, an allyl substitution reaction, an enolate arylation reaction, a hydroformylation reaction, a carbonylation reaction, a hydrosilylation reaction or a boronylation reaction. Reaction conditions and suitable substrates for all of these reaction would be well known to those skilled in the art. Representative examples are provided in the Experimental section hereinbelow.
In certain embodiments of the invention, the NHC-Pd(II) precatalyst or the NHC-Pd(0) catalyst is covalently tethered to a solid support, such as a polymer bead or a resin. For example, the carbene-containing ligand of the precatalyst or the catalyst of the present invention may be covalently tethered to a solid support, such as a Wang resin. Additionally one or more of the cross-coupling substrates may be covalently tethered to a solid support, such as a polymer bead or a resin. Further, in certain embodiments, both substrates may be covalently tethered to a solid support. In certain embodiments, one or more of the substrates or the catalyst or the precatalyst are isolated in a semi-permeable membrane, such as a dialysis bag. In certain embodiments of the invention, the catalyst, for example, through the carbene-containining ligand, may be anchored or supported on a catalyst support, including a refractory oxide, such as silica, alumina, titania, or magnesia; or an aluminosilicate clay, or molecular sieve or zeolite, or an organic polymeric resin or sol gel derived monolithic glass.
Also within the scope of the present invention is the use of the compounds of formula I for any organic synthesis, including, for example, 5 library synthesis and drug discovery. For example, the compounds of formula I may be applied in high throughput synthesis of libraries of compounds for use in the screening of compounds for biological testing. The compounds of formula I are compatible with existing high-throughput synthesis methods.
For example, the compounds of formula I may be used in applications 10 for solid-phase synthesis in which multi-step reactions can be performed on resins in continuous flow or batch manner. Still further, the compounds of formula I may be used in applications for solution phase synthesis in which multi-step reactions can be performed in solution with polymer-supported catalysts in continuous flow or batch manner. Moreover, the compounds of 15 the present invention may be used in coatings of reactor interiors or parts thereof for continuous flow or batch processes.
Further, the compounds of formula I may be attached to solid supports using methods known in the art and used in chemical transformations in this form as described above. The compounds of formula I may also be used, for 20 example, in the synthesis of natural products, agricultural or pharmaceutical ingredients as single compounds regardless of scale, enantiomeric and diastereomeric purity. The compounds of the present invention may be used in the synthesis of materials for electronic, nanotechnology and medical applications. The term "materials" herein is defined as small molecules, oligomers and polymers as single substances or libraries of substances.
Further, the compounds of the present invention may be used in the synthesis of flavors and fragrances regardless of scale, enantiomeric and diastereomeric purity.
As used herein, the terms "comprises", "comprising", "including" and "includes" are to be construed as being inclusive and open ended, and not exclusive. Specifically, when used in this specification including claims, the terms "comprises", "comprising", "including" and "includes" and variations thereof mean the specified features, steps or components are included. These terms are not to be interpreted to exclude the presence of other features, steps or components.
The following non-limiting examples are illustrative of the invention:
EXPERIMENTAL EXAMPLES:
Example 1: Synthesis of the NHC-PdCl2-3-chloropyridine complexes N
R ~ R ~ ~ (IVa) R ~ R
NON ~ ~ + PdCl2 / CI / ~ N N
R / R R ~ R' K2C03 R' ~ R ~ R R
CI-Pd-CI
CI ~ 80 degrees Celsius, 16 h NHC . NCI
'CI
Ila R = i-Pr, R' = H; IPr~HCI Ih R = i-Pr, R' = H; 97%
Ilb R = Et, R' = H; IEt~HCI Ij R = Et, R' = H; 98%
Ilc R = Me, R' = Me; IMes~HCl Ii R = Me, R' = Me; 91 (I) General Synthesis:
In air, a vial was charged with PdCl2 (177 mg, 1.0 mmol), NHC~HCI (1.1 mmol), K2C03 (691 mg, 5.0 mmol) and a stir bar. 3-Chloropyridine (IVa, 4.0 mL) was added, the vial was capped with a Teflon~-line screw cap and heated with vigorous stirring for 16 hours at 80 °C. After cooling to room temperature, the reaction mixture was diluted with CH2C12 and passed through a short pad of silica gel covered with a pad of Celite eluting with CH2C12 until the product was completely recovered. Most of the CH2C12 was removed (rotary evaporator) at room temperature, and the 3-chloropyridine was then vacuum-distilled (water aspirator vacuum) and saved for reuse. The pure complexes were isolated after titrating with pentane, decanting of the supernatant and drying in high vacuum.
(i) Complex Ih.
From IPr~HCI, Ila, (468 mg, 1.1 mmol), the complex Ih (677 mg, 97 %) was obtained as a yellow solid, mp = 240 °C (with decomposition). 'H NMR
(400 MHz, CDC13): 8 8.62 (d, J = 1.6 Hz, 1 H,), 8.54 (d, J = 5.6 Hz, 1 H), 7.57 (d, J =
or L is R6-C=C-R' in which R' and R$ are independently or simultaneously selected from the group consisting of C~_2oalkyl, OC~_2oalkyl, C3_2ocycloalkyl, OC3_ZOCycloalkyl, aryl, O-aryl, heteroaryl and O-heteroaryl, said latter 8 groups being optionally substituted;
one or more of the carbons of the alkyl and cycloalkyl groups of R6 and R' are optionally replaced with -C(O)-, -C(O)NR5- and -C(O)O-;
aryl is an optionally substituted mono- or polycyclic aromatic radical containing from 6 to 14 carbon atoms;
heteroaryl is a mono- or polycyclic heteroaromatic radical containing from 5 to 14 atoms, of which 1 to 5 atoms may be a heteroatom selected from the group consisting of S, O, N and NRS; and optionally substituted means that one or more of the hydrogens on the group are optionally replaced with halo, OH, C~_salkyl, OC~_salkyl, fluoro-substituted C~_salkyl, fluoro-substituted OC~_6alkyl, aryl or aryl that is substituted with 1-5 substituents independently or simultaneously selected from the group consisting of fluoro, C,_4alkyl, OC,_aalkyl, fluoro-substituted C,_4alkyl and fluoro-substituted OC~_4alkyl.
The present invention further relates to a method of preparing a compound of formula I wherein X is halo, in particular CI or Br, the method comprising:
combining a salt of an N-heterocyclic carbene, a ligand L and a metal salt MXb in the presence of a base to form a reaction mixture; and separating the compound of formula I formed in the reaction mixture;
wherein the N-heterocyclic carbene is R3 Ra a R1_Nm~ _R2 a Yo and R' to R4, M, L and a are defined as above and Y is any suitable anion. It is an embodiment of the present invention that when L is a liquid, no solvent is required for the preparation of compounds of formula I.
Also within the scope of the present invention is a method for performing a metal-catalyzed cross-coupling reaction comprising: contacting suitable cross-coupling substrates with a compound of formula I, under conditions for the formation of cross-coupling product, to form a reaction mixture; and, optionally separating the cross-coupling product from the reaction mixture; wherein the compound of formula I is converted to an active catalyst under suitable reaction conditions in the reaction mixture.
It is an embodiment of the present invention that the ligand "L" is a "cooperative" or "throw-away" ligand which aids or improves the performance of the precatalysts of formula I and/or the corresponding Pd(0) catalyst formed from the formula I compounds. For example, L may act to stabilize the catalyst and/or enhance oxidative addition, transmetalation, reductive elimination and/or diastereo- and/or enantioselectivity during reactions catalyzed by these compounds.
The present invention therefore provides a NHC-Pd(II) precatalyst that can be prepared in large scale and stored with little or no deterioration in performance. Further, when the ligand L is a liquid in the NHC-Pd(II) precatalyst of the present invention, the synthesis of the precatalyst can be performed in solvent-less conditions. The NHC-I'd(II) precatalyst of the present invention can form a monoligated NHC-Pd(0) catalytic complex in situ and provides a clearly defined catalyst for use in subsequent coupling reactions. Another advantage of the present invention is that the activation of the catalyst at a desired temperature can be easily achieved by the choice of ligand L. Further, the performance of the catalyst can be easily altered or tuned by the cooperative ligands. Moreover, the NHC-Pd(0) catalyst generated from the NHC-Pd(II) precatalyst has been found to be an effective reagent in a variety of cross-coupling reactions.
For purposes of summarizing the invention and the advantages achieved over the prior art, certain objects and advantages of the invention have been described above. Of course, it is to be understood that not necessarily all such objects or advantages may be achieved in accordance with any particular embodiment of the invention. Thus, for example, those skilled in the art will recognize that the invention may be embodied or carried out in a manner that achieves or optimizes one advantage or group of advantages as taught herein without necessarily achieving other objects or advantages as may be taught or suggested herein.
Other features and advantages of the present invention will become apparent from the following detailed description. It should be understood, however, that the detailed description and the specific examples while indicating preferred embodiments of the invention are given by way of illustration only, since various changes and modifications within the spirit and scope of the invention will become apparent to those skilled in the art from this detailed description.
BRIEF DESCRIPTION OF THE DRAWINGS
The invention will now be described in relation to the drawings in which:
Figure 1 shows the rate studies with complexes Ih and Ij in the alkyl-alkyl cross-couplings: (a) Suzuki reaction; (b) Negishi reaction.
Figure 2 shows a proposed activation mechanism and use of complex Ih.
Figure 3 shows the rate studies with prior art in situ catalyst Pd2(dba)3/Ila and complex Ih in the alkyl-alkyl Negishi reaction: (a) rate comparison with Pd2(dba)3/Ila and complex Ih; (b) TON (turnover number) comparison between Pd2(dba)3/Ila and complex Ih after 1 hour.
Figure 4 shows a proposed mechanism for complex Ih catalyzed Negishi cross-coupling reactions.
DETAILED DESCRIPTION OF THE INVENTION
An array of novel Pd-N-heterocyclic carbene complexes have been prepared and shown to have superior properties in the generation of catalysts in transition metal cross-coupling reactions, in particular compared to catalysts generated in situ from corresponding imidazolium salt and a common Pd source (Pd2(dba)3).
Accordingly, the present invention includes a compound of the formula R3 Ra ~a R'-NYN-R2 MXb L
wherein R' and R2 are independently or simultaneously selected from the group consisting of C~_ZOalkyl, C3_2ocycloalkyl, aryl and heteroaryl, said latter 4 groups being optionally substituted and/or one or more of the CH2 groups in C~-2oalkyl and/or C3_ZOCycloalkyl is optionally replaced with a heteroatom selected from the group consisting of O, S, and NR5;
R3 and R4 are independently or simultaneously selected from the group consisting of H, halo, C~_2oalkyl, OC~_2oalkyl, Cs_2ocycloalkyl, OC3_2ocycloalkyl aryl, O-aryl, heteroaryl and O-heteroaryl, said latter 8 groups being optionally substituted and/or one or more of the CH2 groups in C~_2oalkyl, OCR-2oalkyl, C3_ 2ocycloalkyl and/or OCs_2ocycloalkyl is optionally replaced with a heteroatom selected from the group consisting of O, S, and NR5;
or R3 and R4 are linked to form an optionally substituted 4 to 12-membered ring system which optionally contains one or more heteroatoms selected from the group consisting of O, S, and NR5;
R5 is selected from the group consisting of H and C~_salkyl;
-- is a single or a double bond;
ais1,2or3;
M is a transition metal;
b is an integer representing the number of the anionic ligands X required to fulfill the valency requirements of M;
X is an anionic ligand and when b is greater than 1, each X may be the same or different;
5 L is a 5- to 6-membered optionally substituted N-containing aromatic heterocycle coordinated to M through N, which is optionally benzofused, and/or optionally contains one or more other heteroatoms selected from the group consisting of O, S, and NR5, and/or one or more of the optional substituents on the N-containing aromatic heterocycle is bonded to M in place 10 of one or more X;
or L is R6-C=C-R' in which R' and R$ are independently or simultaneously selected from the group consisting of C~_2oalkyl, OC~_2oalkyl, C3_2ocycloalkyl, OC3_2ocycloalkyl, aryl, O-aryl, heteroaryl and O-heteroaryl, said latter 8 groups being optionally substituted;
one or more of the carbons of the alkyl and cycloalkyl groups of R6 and R' are optionally replaced with -C(O)-, -C(O)NR5- and -C(O)O-;
aryl is an optionally substituted mono- or polycyclic aromatic radical containing from 6 to 14 carbon atoms;
heteroaryl is a mono- or polycyclic heteroaromatic radical containing from 5 to 14 atoms, of which 1 to 5 atoms may be a heteroatom selected from the group consisting of S, O, N and NRS; and optionally substituted means that one or more of the hydrogens on the group are optionally replaced with halo, OH, C~_salkyl, OC~_6alkyl, fluoro-substituted C~_6alkyl, fluoro-substituted OC,_6alkyl, aryl or aryl that is substituted with 1-5 substituents independently or simultaneously selected from the group consisting of fluoro, C~_4alkyl, OC~_4alkyl, fluoro-substituted C,_4alkyl and fluoro-substituted OC~_4alkyl.
The term "C~_ZOalkyl" as used herein means substituted or unsubstituted straight and/or branched chain alkyl groups containing from one to twenty carbon atoms and includes methyl, ethyl, propyl, isopropyl, t-butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, hexadecyl, octadecyl, icosyl and the like.
The term "C3_2ocycloalkyl" as used herein means saturated cyclic or polycyclic alkyl radicals containing from three to twenty carbon atoms and includes cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl, cyclodecyl, cycloundecyl, cyclododecyl, cyclohexadecyl, cyclooctadecyl, cycloicosyl, adamantyl and the like.
The term "aryl" as used herein means a substituted or unsubstituted monocyclic or polycyclic carbocyclic ring system containing one or two aromatic rings and from 6 to 14 carbon atoms and includes phenyl, naphthyl, anthraceneyl, 1,2-dihydronaphthyl, 1,2,3,4-tetrahydronaphthyl, fluorenyl, indanyl, indenyl and the like.
The term "heteroaryl" as used herein means unsubstituted or substituted mono- or polycyclic heteroaromatic radicals containing from 5 to 14 atoms, of which 1-3 atoms are a heteroatom selected from the group consisting of S, O, N and NR'2 where R~2 is H or C~_salkyl, and includes furanyl, thienyl, pyrrolo, pyridyl, indolo, benzofuranyl and the like.
The term "halo" as used herein means halogen and includes chloro, fluoro, bromo, iodo and the like.
The terms "fluoro-substituted C~_salkyl", "fluoro-substituted OC~_salkyl"
and "fluoro-substituted aryl" as used herein means that, in the alkyl or aryl portion of these groups, one or more, including all, of the hydrogen atoms are replaced with a fluorine atom.
The term "optionally substituted" as used herein, unless otherwise stated, means that one or more of the hydrogens on the group are optionally replaced with halo, OH, C~_salkyl, OC,-salkyl, fluoro-substituted C~_salkyl, fluoro-substituted OC~_salkyl, aryl or aryl that is substituted with 1-5 substituents independently or simultaneously selected from the group consisting of fluoro, C~_4alkyl, OC~_4alkyl, fluoro-substituted C~~alkyl and fluoro-substituted OC~_4alkyl.
The term "one or more" as used herein means that from one to the maximum allowable substitutions are allowed.
The present invention includes combinations of groups and substituents that are permitted and would provide a stable chemical entity according to standard chemical knowledge as would be known to those skilled in the art.
The term "polycyclic" or "ring system" as used herein means a cyclic group containing more than one ring in its structure, and includes bicyclic, tricyclic, bridged and spiro ring systems and the like.
It is an embodiment of the invention that the compounds of formula I
include those in which R' and R2 are independently or simultaneously C,_ ~oalkyl, C3_~6cYcloalkyl or aryl, wherein the latter three groups are optionally substituted. In an embodiment of the invention, R' and R2 are independently or simultaneously optionally substituted C3_~ocycloalkyl or optionally substituted aryl. In another embodiment of the invention, R' and R2 are independently or simultaneously optionally substituted C4_6cycloalkyl or optionally substituted phenyl. In an alternative embodiment of the invention, R' and R2 are independently or simultaneously optionally substituted cyclopropane, adamantyl or optionally substituted phenyl.
In an embodiment of the invention, R3 and R4 are independently or simultaneously H, or C~_~oalkyl, C3_~6cYcloalkyl or aryl, wherein the latter three groups are optionally substituted. In a further embodiment, R3 and R4 are independently or simultaneously H or optionally substituted C3_~ocycloalkyl or optionally substituted phenyl. In another embodiment of the invention, R3 and R4 are H. In a still further embodiment of the invention, R3 and R4 are linked to form an optionally substituted 6-membered ring system, such as phenyl.
It is also another embodiment of the invention that a is 1 or 2, specifically 1.
In an embodiment of the invention, M is selected from the group consisting of Fe, Ru, Os, Co, Rh, Ir, Ni, Pd and Pt. In another embodiment of the invention, M is selected from the group consisting of Fe, Ru, Rh, Ir, Pd and Pt. In a further embodiment of the invention, M is Pd, Rh, or Pt. In a still further embodiment of the invention, M is Pd or Pt, suitably Pd.
In an embodiment of the inventon, L is selected from the group consisting of pyridine, pyriazine, imidazole, quinoxaline and quinoline, all of which are optionally substituted. In an embodiment of the invention, the optional substituent is electron withdrawing in nature.
In a further embodiment of the invention, L is selected from the group consisting of Rs Nw R1° Rs N
R7 ~ , R9 and ~N
Ra R7 'Ra in which R6, R', Ra, R9 and R'° are independently or simultaneously selected from the group consisting of H, halo, OH, C~_6alkyl, OC,_salkyl, C3_~cylcloalkyl, OCs_7cycloalkyl, fluoro-substituted C~_6alkyl, fluoro-substituted OC~_salkyl, aryl or aryl that is substituted with 1-5 substituents independently or simultaneously selected from the group consisting of fluoro, C~_4alkyl, OC~_ 4alkyl, fluoro-substituted C~_4alkyl and fluoro-substituted OC~~alkyl. In a further embodiment of the invention, Rs, R', Ra, R9 and R'° are independently or simultaneously selected from the group consisting of H, halo, C,_~alkyl, C3_ scycloalkyl and aryl. In a still further embodiment of the invention, R6, R', Ra, R9 and R'° are independently or simultaneously selected from the group consisting of H, Br, CI, C~_fialkyl, fluoro-substituted C~_salkyl, C5_6cycloalkyl and phenyl. In a more particular embodiment of the invention, R6, R7, Ra, R9 and R'° are independently or simultaneously selected from the group consisting of H, CH3, CF3, Br, CI and phenyl. It is another embodiment of the invention that one or more R6, R', Ra, R9 and R'°, in particular R5 or R9, on the N-containing aromatic heterocycle is bonded to M in place of one or more X.
In an embodiment of the invention, L is Rs N Rio R~ ~ R9 Ra in which the embodiments for R6, R', R8, R9 and R'° are as defined above.
It is an embodiment of the present invention that the ligand "L" is a "cooperative" or "throw-away" ligand which aids or improves the performance of the precatalysts of formula I and/or the corresponding Pd(0) catalyst formed from the formula I compounds. For example, L may act to stabilize the catalyst and/or enhance oxidative addition, transmetalation, reductive elimination and/or diastereo- and/or enantioselectivity during reactions catalyzed by these compounds.
It is an embodiment of the invention that X is F, Br, CI, I or OC(O)CH3.
It is a more particular embodiment of the invention that X is CI or Br, suitably CI. It is a further embodiment of the invention that, when b is greater than one, each of X may be the same or different. For example, when b is 2, one X may be CI and the other may be Br, or they both may be CI or Br, suitably CI.
It is an embodiment of the invention that the optional substituents are selected from halo, C~_6alkyl, OC~_øalkyl, aryl and aryl that is substituted with 1-5 substituents independently or simultaneously selected from the group consisting of fluoro, G~_4alkyl, OC~_4alkyl, fluoro-substituted C,_4alkyl and fluoro-substituted OC~~alkyl. Further, it is an embodiment of the invention that the optional substituents are selected from F, methyl, ethyl, isopropyl, OCH3, CF3, OCF3, phenyl and phenyl that is substituted with 1-3 substituents, suitably 1-2 substituents, more suitably 1 substituent, independently or simultaneously selected from the group consisting of fluoro, methyl, OCH3, CF3 and OCF3.
In an embodiment of the invention, the compound of formula ! is selected from:
R R R ~ R R ~ R
\ N R ~ \ N N ~ ~ \ N N '~
Y 1 / R R ~ Y ~ / R
R M b ' / ' R MXb R ' MXb , L R L R L R
la Ib Ic R
R ~ R
NYN R ~ \ N N ~ R R
R MXb R ~ ~ ' R Xb R / / ~ Y ' /
R MXb R
L
Id 1e If R R
and N ~ N
MXb L
Ig in which R is H, methyl, ethyl, isopropyl, OCH3, CF3, OCF3 or F, and M, X, b, _ 5 --- and L are as defined above.
In another embodiment of the invention, the compound of formula I is selected from:
n / w N N \~ /% N N ~ % ~ N N
CI-~ CI
CI-Pd-CI N CI-Pd-CI
N ~ ~ ' N
v -CI
CI ~CI
Ih I~ IJ
/ j N N \ ~ ' N N
/i \
CI-~-CI
CI-Pd-CI i CI-Pd-Cf ,N and v 'CI
CI ~CI
Ik Im In In another embodiment of the invention, the compound of formula f is:
R3 Ra R1_ ~ _R2 X-M
N ~ I
to wherein R', R2, R3, R4, M, -~ and X are as defined in Formula I.
In yet another embodiment of the invention the compound of Formula I
is:
iPr iPr iPr iPr ~ I n ~ I ~ I n ~
N N ~ \ N N
iPr Y iPr ~r iPr Y iPr CI-M ~ CI-M
N ~. I N W I
Ip Iq In accordance with another of its aspects, the present invention includes a method of preparing the compounds of formula I, wherein X is CI or Br, comprising combining a salt of an N-heterocyclic carbene, a ligand L and a metal salt MXb in the presence of a base to form a reaction mixture; and separating the compounds of formula I formed in the reaction mixture, wherein the N-heterocyclic carbene is R3 Ra a R'-I~~ -R2 Ye and R' to R4, L, M, X, -- and b have the meanings provided above for Formula I and Y is any suitable counteranion, such as F-, CI-, Br , I- or PFs .
For example, compounds of the invention may be prepared, by the reaction sequence shown in Scheme 1:
a Ligand L a R'-NON-R2 + MXb R'-NYN-R2 Base Y~ MXb L
(II) (III) (I) Scheme 1 Accordingly, N-heterocyclic carbene salt of formula II in which R' to R4 and a are as defined in formula I, -- is a single or double bond (as appropriate) and Y is any suitable counteranion, may be reacted with transition metal complex of formula III in which M and b are as defined in formula I and X is CI or Br, in the presence of a base and ligand L as defined in formula I, and optionally, a solvent, to provide compounds of formula I by direct C-H insertion. A solvent may not be required when L is a liquid. Advantageously, the reaction may be performed without special precautions to exclude water or oxygen. For example, the reaction may be performed in air. Compounds of formula II, III
and L are either commercially available or may be prepared using methods known in the art. The anion Y may be any suitable anion, for example, F-, CI-, Br~, I-or PFs . The base may be any suitable base which is compatible with the compounds of formula II, III and L. One of ordinary skill in the art would know the appropriate bases which are suitable for use in the formation of compounds of formula I. For example, the base may be Cs2COs, K2C03, Na2COs, K3P03, CaC03 or NaOAc. Suitably, the base is Cs2C03, K2C03 or Na2C03. Compounds of formula II, III and L are suitably reacted in the presence of the base at a temperature of about 40°C to about 100°C. More suitably, the reaction mixture conducted at a temperature of about 60°C
to about 80°C. It has been shown that the reaction does provide optimal yields without the presence of a suitable base. In an embodiment of the invention, the base is present in excess amounts, for example, at least about 1.2 times, suitably at least about 5 times, the amount of the carbene and metal salts.
This contrasts with the method of Bertogg et al. [Bertogg, A.; Camponovo. F.;
Togni, A. Eur. J. Inorg. Chem. (2005), 347-356] which does not utilize an extra base, like the method of the present invention. The method described in Bertogg also results in the formation of undesirable dimeric side products which make up approximately 50°l0 of the yield from the reaction.
For compounds of Formula I, wherein X is other than CI or Br, the method of Bertogg [Bertogg, A.; Camponovo. F.; Togni, A. Eur. J. Inorg.
Chem. (2005), 347-356] or Marion et al. [Marion, N.; Ecarnot, E.C.; Navarro, O.; Amoroso, D.; Bell, A.; Nolan, S.P. J. Org. Chem. published on the web April 11, 2006, and references cited therein] may be utilized.
The isolation of the desired compound of the formula I is achieved using standard purification techniques. For example, the compound of formula I is separated from the reaction mixture by purification techniques selected from the group consisting of filtration, recrystallization, extraction, chromatography and combinations thereof.
Also within the scope of the present invention is a method for performing a metal-catalyzed cross-coupling reaction comprising: contacting suitable cross-coupling substrates with a compound of formula I, under conditions for the formation of cross-coupling product, to form a reaction mixture; and, optionally separating the cross-coupling product from the reaction mixture; wherein the compound of formula I is converted to an active catalyst under suitable reaction conditions in the reaction mixture.
Typically, suitable reaction conditions include the use of a suitable base, solvent and reaction temperatures as would be well known to those skilled in the art.
The present invention further includes a use of the compounds of formula I in metal catalyzed cross-coupling reactions. The invention also includes a use of the compounds of formula I as a pre-catalyst in a metal-catalyzed cross-coupling reaction.
In an embodiment of the invention, the cross-coupling reaction is for example, but not limited to, a Negishi coupling reaction, a Heck coupling reaction, a Suzuki coupling reaction, a Hiyama coupling reaction, a Sonogashira coupling reaction, a Stille coupling reaction, a Kumada coupling reaction, a Buchwald-Hartwig amination reaction, an allyl substitution reaction, an enolate arylation reaction, a hydroformylation reaction, a carbonylation reaction, a hydrosilylation reaction or a boronylation reaction. Reaction conditions and suitable substrates for all of these reaction would be well known to those skilled in the art. Representative examples are provided in the Experimental section hereinbelow.
In certain embodiments of the invention, the NHC-Pd(II) precatalyst or the NHC-Pd(0) catalyst is covalently tethered to a solid support, such as a polymer bead or a resin. For example, the carbene-containing ligand of the precatalyst or the catalyst of the present invention may be covalently tethered to a solid support, such as a Wang resin. Additionally one or more of the cross-coupling substrates may be covalently tethered to a solid support, such as a polymer bead or a resin. Further, in certain embodiments, both substrates may be covalently tethered to a solid support. In certain embodiments, one or more of the substrates or the catalyst or the precatalyst are isolated in a semi-permeable membrane, such as a dialysis bag. In certain embodiments of the invention, the catalyst, for example, through the carbene-containining ligand, may be anchored or supported on a catalyst support, including a refractory oxide, such as silica, alumina, titania, or magnesia; or an aluminosilicate clay, or molecular sieve or zeolite, or an organic polymeric resin or sol gel derived monolithic glass.
Also within the scope of the present invention is the use of the compounds of formula I for any organic synthesis, including, for example, 5 library synthesis and drug discovery. For example, the compounds of formula I may be applied in high throughput synthesis of libraries of compounds for use in the screening of compounds for biological testing. The compounds of formula I are compatible with existing high-throughput synthesis methods.
For example, the compounds of formula I may be used in applications 10 for solid-phase synthesis in which multi-step reactions can be performed on resins in continuous flow or batch manner. Still further, the compounds of formula I may be used in applications for solution phase synthesis in which multi-step reactions can be performed in solution with polymer-supported catalysts in continuous flow or batch manner. Moreover, the compounds of 15 the present invention may be used in coatings of reactor interiors or parts thereof for continuous flow or batch processes.
Further, the compounds of formula I may be attached to solid supports using methods known in the art and used in chemical transformations in this form as described above. The compounds of formula I may also be used, for 20 example, in the synthesis of natural products, agricultural or pharmaceutical ingredients as single compounds regardless of scale, enantiomeric and diastereomeric purity. The compounds of the present invention may be used in the synthesis of materials for electronic, nanotechnology and medical applications. The term "materials" herein is defined as small molecules, oligomers and polymers as single substances or libraries of substances.
Further, the compounds of the present invention may be used in the synthesis of flavors and fragrances regardless of scale, enantiomeric and diastereomeric purity.
As used herein, the terms "comprises", "comprising", "including" and "includes" are to be construed as being inclusive and open ended, and not exclusive. Specifically, when used in this specification including claims, the terms "comprises", "comprising", "including" and "includes" and variations thereof mean the specified features, steps or components are included. These terms are not to be interpreted to exclude the presence of other features, steps or components.
The following non-limiting examples are illustrative of the invention:
EXPERIMENTAL EXAMPLES:
Example 1: Synthesis of the NHC-PdCl2-3-chloropyridine complexes N
R ~ R ~ ~ (IVa) R ~ R
NON ~ ~ + PdCl2 / CI / ~ N N
R / R R ~ R' K2C03 R' ~ R ~ R R
CI-Pd-CI
CI ~ 80 degrees Celsius, 16 h NHC . NCI
'CI
Ila R = i-Pr, R' = H; IPr~HCI Ih R = i-Pr, R' = H; 97%
Ilb R = Et, R' = H; IEt~HCI Ij R = Et, R' = H; 98%
Ilc R = Me, R' = Me; IMes~HCl Ii R = Me, R' = Me; 91 (I) General Synthesis:
In air, a vial was charged with PdCl2 (177 mg, 1.0 mmol), NHC~HCI (1.1 mmol), K2C03 (691 mg, 5.0 mmol) and a stir bar. 3-Chloropyridine (IVa, 4.0 mL) was added, the vial was capped with a Teflon~-line screw cap and heated with vigorous stirring for 16 hours at 80 °C. After cooling to room temperature, the reaction mixture was diluted with CH2C12 and passed through a short pad of silica gel covered with a pad of Celite eluting with CH2C12 until the product was completely recovered. Most of the CH2C12 was removed (rotary evaporator) at room temperature, and the 3-chloropyridine was then vacuum-distilled (water aspirator vacuum) and saved for reuse. The pure complexes were isolated after titrating with pentane, decanting of the supernatant and drying in high vacuum.
(i) Complex Ih.
From IPr~HCI, Ila, (468 mg, 1.1 mmol), the complex Ih (677 mg, 97 %) was obtained as a yellow solid, mp = 240 °C (with decomposition). 'H NMR
(400 MHz, CDC13): 8 8.62 (d, J = 1.6 Hz, 1 H,), 8.54 (d, J = 5.6 Hz, 1 H), 7.57 (d, J =
8.2 Hz, 1 H), 7.52 (t, J = 7.7 Hz, 2H), 7.37 (d, J = 7.7 Hz, 4H), 7.16 (s, 2H), 7.09 (dd, J = 8.0 Hz, 5.7 Hz, 1 H), 3.18 (m, 4H), 1.50 (d, J = 6.7 Hz, 12H), 1.14 (d, J = 6.8 Hz, 12H). '3C NMR (100 MHz, CDC13): 8153.5, 150.5, 149.4, 146.7, 137.4, 135.0, 132.0, 130.3, 125.1, 124.3, 124.1, 28.7, 26.3, 23.2. Anal.
Calcd.
for C32H4oC13NsPd: C, 56.57; H, 5.93; N, 6.18. Found: C, 56.90; H, 5.99; N, 6.52.
(ii) The above reaction for the preparation of complex Ih was repeated using other bases. The percent yield of Ih was as follows:
Na2C03 - 98%
K2C03 - 97%
K3POs - 43%
CaC03- 25%
Cs2C03- 93%
NaOAc- 60%
It should be noted that reactions performed in the absence of base did not provide optimum amounts of desired products.
(iii) The number of equivalents of base in the above reactions was also varied, with the following results:
2 equiv NaOAc - 60% compound Ih 2 equiv K2C03 - 80% compound Ih 1.25 and 2.5 equiv. Na2COs- 73% compound Ih (iv) Using the general synthesis in part (i) above, the corresponding Pt complex (R = iPr, R' = H) was made in 60% yield using PtCl2 and K2C03 as base.
(v) Using the corresponding saturated version of Ila, compound Ik was also prepared:
R ~ R
N N
R ~ R
CI-Pd-CI
I
N
CI
Ik R = iPr (vi) By replacing 3-chloropyridine with 2-phenyl pyridine, compounds Ip was prepared in 86% using Cs2C02 as base.
iPr iPr ~ I n ~
N N
iPr ~ iPr CI-M
N
Ip Example 2: Catalytic Activity of the NHC-Pd catalysts Ih, Ii and Ij in alkyl-alkyl cross-coupling reactions Pd-NHC catalyst Ih, Ij or 1i Br +
(1 mol%) and nBuZnBr (Negishi) or tri-n-butylborane (Suzuki) Complex Ih (Example 1, 1 mol %) was subjected to standard alkyl-alkyl Suzuki and Negishi cross-coupling reactions. Reaction conditions are provided in Table 1. The reactions were rapid (Suzuki 5 minutes, Negishi 30 minutes). Quantitative formation of the reaction product was observed at room temperature (Table 1 ).
Example 3: Rate studies with complexes Ih and Ij in alkyl-alkyl cross-couplings shown in Example 2 The results of the rate studies with complexes Ih and Ij (see Example 1) in the alkyl-alkyl cross-couplings (a) Suzuki reaction, (b) Negishi reaction are shown in Figure 1. The yields were determined by GC/MS against a calibrated internal standard (undecane). As seen in Figure 1, the rate of the reaction with complex Ij was much slower than with complex Ih. While not wishing to be limited by theory, these results are suggestive that bulky NHC ligands lead to fast reductive elimination, which suppresses undesired side reactions or catalyst decomposition in a manner analogous with bulky phosphines. Since complexes Ih, Ij and Ii are air- and water tolerant and do not decompose upon standing, heating Ih at 100 °C in DMSO-ds for 24 hours led to no visable decomposition (by 'H and '3C NMR spectroscopic analysis). Thus, it is unlikely that pyridine dissociation initiates catalyst activation considering the high stability of complex Ih. Rather, rapid reduction facilitated by the organometallic reagent takes place followed by pyridine dissociation from the generated Pd(0) species (Figure 2).
Example 4: Mechanistic Studies: Activation and use of complex Ih Complex Ih (Example 1 ) was treated with 2 equivalents of n-heptylzinc bromide and the reaction mixture was analyzed by GC/MS. From this analysis, the formation of n-tetradecane and liberation of 3-chloropyridine was observed. DFT calculations at the B3LYP/DZVP level showed that the binding enthalpy of 3-chloropyridine to NHC-ligated Pd(II) is 4.5 kcal mol-~ higher than to Pd(0). Also the dissociation energy of PH3 is 16.5 kcal mol-1 compared to 19.4 kcal mol-~ for the 3-chloropyridine.
Example 5: Comparison between in situ catalyst and NHC-PdCl2-3-chloropyridine (Ih) complexes in the alkyl-alkyl Negishi reaction A significant increase in rate was observed when catalysis with complex Ih (Example 1) at 1 mol % was compared to the prior art Pd2(dba)3/Ila in situ protocol at 4 mol % (Figure 3a). Due to extremely fast rates at 1 mol % of Ih, it was not possible to reliably measure the reaction rate, therefore, a loading of 0.1 mol % was used (Figure 3b). A comparison with the in situ protocol is shown after 1 hour. Given that both reactions were 30 % complete at that time, the apparent (turnover numbers) TONs suggest, assuming the same 5 active catalyst is generated when employing the in situ protocol, that only 0.1 mol % of active catalyst is actually formed, even though 4 mol % of the precursors are used. !t should be pointed out that, in the prior art Pd2(dba)3/Ila in situ protocol, the catalysis was weighed in a glove box, taking great care to avoid contact with air and water. Using the compounds of formula I of the 10 present invention, the catalyst (or precatalyst) could be weighed in the open with no special precautions to avoid contact with air. The advantages in reaction time and yield when the compounds of formula I are used in the metal-catalyzed cross-coupling reaction are clearly seen in the graphs shown in Figure 3.
Example 6: Optimization of Suzuki conditions for boronic acids CI B(OH)2 Pd-NHC catalyst Ih, ij or Ii ~. OMe (1-2 mol%) i Solvent/Base OMe Temperature (degrees Celsius) Complexes Ih, Ij or Ii was subjected to a variety of Suzuki reaction conditions (Table 2). It was found that all complexes functioned as excellent catalysts at 80 °C. !n comparison to complexes Ij and Ii, it was found that complex !h was advantageous as it was possible to conduct reactions in both dioxane and i PrOH at room temperature with a judicious choice of base (Table 2, entries, 10 and 12).
Example 7: Optimization of Suzuki conditions for potassium trifluoroborates Pd-NHC catalyst Ih / OMe (2 mol%) Solvent/Base OMe Temperature (degrees Celsius) Expansion of the protocol in Example 6 to potassium trifloroboroates was accomplished by simply changing the solvent to methanol (Table 3, entries 2, 5, 6-8).
Example 8: Suzuki cross-coupling reactions substrate scope There are 4 different protocols for this reaction dependent on the coupling partners. Robust functionality can be coupled at room temperature in isopropyl alcohol (IPA) using KOt-Bu as base, while base-sensitive groups may be coupled utilizing K2COs at 60°C. For relatively hindered substrates sensitive to KOt-Bu and where K2C03 is ineffective, KOH may be used at room temperature. Optimal to the success is ensuring that the precatalyst is activated. When utilizing KOt-Bu, a change in reaction solution color, normally to orange or red, is observed. When utilizing K2C03 or KOH, in the absence of strongly colored materials the reaction is generally complete when the solution is grey in color and contains noticeable precipitate.
The employment of a variety of reaction conditions allowed a large array of hindered biaryls and drug-like heteroaromatics to be easily synthesized using Suzuki cross-coupling reaction conditions (Table 4). A notable example is the synthesis of 19 (Table 4), which when used in combination with triethylphosphine has been demonstrated to form a highly effective asymmetric Morita-Baylis-Hillman (MBA) protocol [McDougal, N.T.; Schaus, S.E. J. Am. Chem. Soc. (2003) 125, 12094-12095]. Methods A, B, C and D
are described in detail below. Use of IPA/t-BuOK (Method A) allowed for rapid cross-coupling at room temperature whereas more sensitive coupling partners were effectively coupled utilizing mild K2C03 in dioxane (Method B) or methanol in the case of potassium trifluoroborates (Method C).
(i) Procedure for Method A.
In air, a vial was charged with potassium tert-butoxide (154 mg, 1.30 mmol) and complex Ih (6.8 mg, 0.01 mmol) and the vial was sealed and purged with argon (3x). Technical grade isopropanol (1.0 mL) was added and the contents were stirred at room temperature until a colour change from yellow to red/brown was observed (~10 min). Under a cone of argon, the boronic acid (1.20 mmol) was added, the vial was resealed with a septum and the organohalide (1.00 mmol) injected via microlitre syringe. Alternatively, if the boronic acid was soluble in isopropanol, it was added as a solution (1.0 mL).
The solution was stirred at room temperature for the indicated period of time.
The reaction was then diluted with diethyl ether (2 mL) and transferred to a round bottom flask. The reaction vial was rinsed with additional diethyl ether (2 mL) and combined with the previous dilution. Each reaction was performed in duplicate and the contents were combined, concentrated onto silica gel and purified by flash chromatography.
(ii) Procedure for Method B.
In air, a vial was charged with complex Ih (6.8 mg, 0.01 mmol), potassium carbonate (207 mg, 1.50 mmol), the boronic acid (0.6 mmol) and the organohalide (0.5 mmol). The vial was sealed with a septum and purged with argon (3X). Dioxane (2.0 mL) was added and the contents were stirred at 60°C for the specified period of time. The reaction was then diluted with diethyl ether (2 mL) and transferred to a round bottom flask. The reaction vial was rinsed with additional diethyl ether (2 mL) and combined with the previous dilution. Each reaction was performed in duplicate and the contents were combined, concentrated onto silica gel and purified by flash chromatography.
(iii) Procedure for Method C.
In air, a vial was charged with complex Ih (6.8 mg, 0.01 mmol), potassium carbonate (207 mg, 1.50 mmol), the potassium trifluoroborate (0.55 mmol) and the organohalide (0.5 mmol). The vial was sealed with a septum and purged with argon (3x). Technical grade methanol (2.0 mL) was added and the contents stirred at 60°C for the specified period of time. The reaction was then diluted with diethyl ether (2 mL) and transferred to a round bottom flask.
The reaction vial was rinsed with additional diethyl ether (2 mL) and combined with the previous dilution. Each reaction was performed in duplicate and the contents were combined, concentrated onto silica gel and purified by flash chromatography.
(iv) Procedure for Method D.
Method B was followed however in the place of solid potassium carbonate, solid KOH (84 mg, 1.50 mmol) was utilized. Additionally, the reaction was carried out at room temperature instead of 60°C.
Example 9: Evaluation of Complex Ih in the Negishi reaction A comprehensive evaluation of complex Ih in the Negishi cross-coupling reaction was performed. The results presented in Table 5 demonstrate that complex Ih was able to catalyze the cross-coupling of organo-chlorides, bromides and iodides, aryl triflates and alkyl tosylates and mesylates in all possible pairings of potential cross-coupling substrates, including all possible hybridization states of the atoms specifically involved in the coupling, in high yield at room temperature (Table 5, entries 1-3, 6-8, 12-14 and 17-19).
There were 4 main protocols for this reaction dependant on organohalide and carbon hybridization present in the coupling partners. Whilst most reactions are carried out at room temperature, sterically encumbered partners were optimally warmed to 60-70°C to ensure efficient cross-coupling.
Furthermore, the addition of 2 equivalents (based on organozinc) of Liar or LiCI (available from Aldrich as 1 M anhydrous solutions in THF or DMI) is important to effect cross-coupling in some reaction types (see Protocols below). Efficient catalyst formation and reaction is normally indicated by a slow color change from pale yellow to a deep brown-colored solution when employing zinc made by the Hou protocol in DMI (Org. Lett. 2003, 5, 423). If this change is rapid, (1-2 seconds) this is indicative of a failed reaction and is normally the result of ineffective catalyst activation, which could be due to the steric and/or electronic properties of the organozinc reagent. Use of organozincs formed by Rieke zinc does not show the same color change. Additionally, the use of n-BuLi for formation of aryl zincs should be avoided as the generated butyl halide is a capable coupling partner for complex Ih due to its high reactivity.
Cross-Coupling Procedures: All cross-coupling reactions were run with a final solvent volume of 2.4 mL.
Solvent ratios Alkyl bromides: DMI/NMP: THF, 1:2 Alkyl chlorides, iodides, tosylates and mesylates: DMI/NMP: THF, 3:1 Aryl bromides: DMI/NMP: THF, 1:2 Aryl chlorides, triflates: DMI/NMP:THF, 3:1 (sp3X-sp3ZnX): A vial was charged with Ih (3.4 mg, 1 mol%), Liar (139.0 mg, 1.6 mmol, transferred under a filter cone flowing with inert gas) and a stirbar, after which it was sealed with a septum and purged under an inert atmosphere. THF (X mL) and DMI (X mL) or NMP (X mL) were then added and the suspension stirred until the solids dissolved after which the organozinc (0.8 mL, 1.0 M in DMI or NMP, 0.8 mmol) and the organohalide or pseudo halide (0.5 mmol) were added. The septum was replaced with a Teflon-lined screw cap under an inert atmosphere (e.g. under a cone of argon, not necessarily in a glove box) and the reaction stirred for 2h. After this time, the mixture was diluted with ether (15 mL) and washed successively with 1 M Na3EDTA solution (prepared from EDTA and 3 equiv of NaOH), water and brine. After drying (anhydrous MgSOa) the solution was filtered, the solvent removed in vacuo, and the residue purified by flash chromatography.
(sp3X-sp2ZnX): A vial was charged with Ih (3.4 mg, 1 mol%) and under an inert atmosphere ZnCl2 (107 mg, 0.8 mmol, transferred under a filter cone flowing with inert gas) and a stirbar were added. The vial was then sealed with a septum and purged under an inert atmosphere. THF (0.8 mL) was added followed by the requisite Grignard reagent (0.8 mL, 1.0 M in THF, 0.8 mmol) and stirring continued for 15 minutes at which time a white precipitate formed.
Under an inert atmosphere, Liar (139.0 mg, 1.6 mmol), NMP (0.8 mL) or DMI
(0.8 mL) and the organohalide or psuedo halide (0.5 mmol) were added. The septum was replaced with a Teflon-lined screw cap under an inert atmosphere and the reaction stirred for 2h. After this time, the mixture was diluted with ether (15 mL) and washed successively with 1 M Na3EDTA
5 solution (prepared from EDTA and 3 equiv of NaOH), water and brine. After drying (anhydrous MgS04) the solution was filtered, the solvent removed in vacuo, and the residue purified by flash chromatography.
(sp2X-sp3ZnX): A vial was charged with Ih (3.4 mg, 1 mol%), Liar (139.0 mg, 1.6 mmol, transferred under a filter cone flowing with inert gas) and a stirbar 10 after which it was sealed with a septum and purged under an inert atmosphere. THF (X mL) and DMI (X mL) or NMP (X mL) were then added and the suspension stirred until the solids dissolved after which the organozinc (0.8 mL, 1.0 M in DMI or NMP, 0.8 mmol) and the organohalide or psuedo halide (0.5 mmol) were added. The septum was replaced with a 15 TefIonC~-lined screw cap under an inert atmosphere and the reaction stirred for 2h. After this time, the mixture was diluted with ether (15 mL) and washed successively with 1 M Na3EDTA solution (prepared from EDTA and 3 equiv of NaOH), water and brine. After drying (anhydrous MgS04), the solution was filtered, the solvent removed in vacuo, and the residue purified by flash 20 chromatography.
(sp2X-sp2ZnX): In air, a vial was charged with Ih (3.4 mg, 1 mol%) and ZnCl2 (0.8 mmol, transferred under a filter cone flowing with inert gas) and a stirbar were added. The vial was then sealed with a septum and purged under an inert atmosphere. THF (X mL) was then added followed by the requisite 25 Grignard reagent (0.8 mL, 1.0 M in THF, 0.8 mmol) and stirring continued for 15 minutes at which time a white precipitate formed. NMP (X mL) was then added followed by the organohalide or pseudo halide (0.5 mmol) and the septum was replaced with a Teflon~~-lined screw cap under an inert atmosphere and the reaction stirred for 2h. After this time, the reaction 30 mixture was diluted with ether (15 mL) and washed successively with 1 M
Na3EDTA solution (prepared from EDTA and 3 equiv of NaOH), water and brine. After drying (anhydrous MgS04) the solution was filtered, the solvent removed in vacuo, and the residue purified by flash chromatography.
Example 10: Negishi cross-coupling reactions substrate scope As seen in Table 6, functionalization of the reactants did not diminish the generality of the protocols described in Example 9, with sp3(RX)-sp3(RZnX), spa-sp2, sp2-spa and sp2-sp2 cross-coupling reactions easily accomplished with 1 mot % complex Ih. Coupling of a range of alkyl bromides, chlorides and tosylates was achieved at room temperature (Table 6, compounds 21-26).
Remarkably, by careful choice of reaction conditions it was possible to selectively couple a bromide in the presence of a chloride (Table 6, compound 21 ). An array of functionality was tolerated including esters, nitrites, amides and acetals (Table 6, 21-26). Noteworthy examples are the coupling of (S)-citronellyl bromide in high yield (Table 6, compound 27) and the stability of the TMS group in the reaction conditions (Table 6, compounds 25, 28 and 29).
The coupling of alkyl zinc reagents with aryl halides or aryl triflates occurred in high yield with no transmetalation to the aryl zinc observed (Table 6, compounds 31-34). Aryl halides, as expected, proved to be excellent coupling partners. Accordingly, the facile synthesis of a range of drug-like heteroaromatics and sterically congested biaryls was accomplished in high yield (Table 6, compounds 35-41 ). A significant entry is the coupling of o-chlorotoluene and 2,4,6-triisopropylphenylzinc chloride at 60 °C (Table 6, compound 35). N-Boc protected indole, pyridine, and multiple heteroatom containing heterocycles were well tolerated (Table 6, compounds 31, 32, 34, 37, 39-41) Finally, the cross-coupling of a chiral zinc reagent with an acyl chloride (Table 6, compound 33) proceeded Without concomitant decarbonylation, demonstrating the mildness of this protocol.
Example 11: Heck cross-coupling reaction Br O O' \
O' \ W
A vial was charged with complex Ih (17.0 mg, 0.025 mmol, 5 mol%) as defined in Example 1, Cs2C03 (326 mg, 1.0 mmol) and a stir bar. The air was replaced with an inert gas (Ar) and dry DMA was introduced, followed by bromobenzene (53 pL, 78.5 mg, 0.5 mmol), tert-butyl acrylate (117 NL, 103 mg, 0.8 mmol) and n-undecane (GC internal standard, 50 NL). The reaction was stirred at 120°C for 18 hours, then cooled to room temperature, diluted with hexane and analyzed by GC/MS after passing through a short pad of silica gel. Quantitative conversion to (E)-tent butyl cinnamate was observed by GC/MS. GC retention time and EI fragmentation pattern were identical to commercially available material (Aldrich).
Example 12: Buchwald Hartwig coupling reaction C~
o C~
In air, potassium tent-butoxide (127 mg, 1.10 mmol) and complex Ih (6.8 mg, 0.01 mmol, 1.0 mol%) as defined in Example 1 were weighed into a vial with a stir bar and the vial was capped with a septum. The atmosphere was replaced With inert gas (Ar) and 1 mL of dry DME added and stirred until all the solids had dissolved. Chlorobenzene (102 pL, 112.56 mg, 1.0 mmol) and morpholine (96 pL, 96 mg, 1.10 mmol) were then added in quick succession with rapid stirring. The septum was then replaced with a Teflon~ lined cap under inert gas (Ar) and the vial heated at 50°C for 1 hour. After this time the reaction mixture was cooled and partitioned between water and ether, the organic phase was dried (anhydrous MgS04), filtered, and the solvent removed. The resultant residue was purified by flash chromatography eluting with 9:1 pentane:ether. N-Phenylmorpholine was obtained as a white solid 155 mg, 95% yield.
Example 13: Buchwald-Hartwig coupling reactions substrate scope H R,.
Ar-X + ' N-Ar R, ~ N ~ R" R,r A study of the Buchwald-Hartwig coupling reaction substrate scope was performed and the results are shown in Table 7. The general experimental conditions were as follows:
A vial was charged with Ih (14 mg, ~2 mol°l°), KOt-Bu (135.0 mg, 1.2 mmol corrected for purity) and a stirbar were added after which it was sealed with a septum and purged with an inert atmosphere. The amine (1.1 mmol) and organohalide (1.0 mmol) were added and stirred rapidly for 1-2 min. When using 2,6-diisopropylaniline the reaction turns orange immediately; stirring should continue until the solution becomes dark orange to red (note: a green to dark green solution indicates a failure to form sufficient active catalyst).
After this time, DME (1 mL) was added and the septum was replaced with a Teflon-lined screw cap under an inert atmosphere and the reaction stirred at RT or 50°C until complete. After this time, the mixture was diluted with TBME
(15 mL) and washed with water. After drying (anhydrous Na2S04, the use of MgS04 can be problematic), the solution was filtered, the solvent removed in vacuo, and the residue purified rapidly by flash chromatography and stored under an inert atmosphere. Pre-absorption of the crude amine product onto silica should be avoided as this practice has been found to lead to poor recovery.
Example 14: Kumada Reaction Effective coupling partners are aryl chlorides and bromides. Simple couplings can be done at room temperature without the addition of LiCI; if this proves unproductive, heating at 60 or 70°C normally facilitates the cross-coupling. If these conditions fail for challenging partners, 2 or 3 equivalents (based on organomagnesium reagent) of anhydrous LiCI may be added and the reaction temperature varied from RT to 70 °C.
A vial was charged with Ih (7 mg, 2 mol%) and LiCI (67.0 mg, 1.6 mmol) as necessary followed by a stirbar under an inert atmosphere. The vial was then sealed with a septum and purged under an inert atmosphere after which DME
(0.8 mL) was added and the suspension was stirred until Ih had dissolved.
After this time, the organohalide (0.5 mmol) and the organomagnesium (0.8 mL, 1.0 M in THF or ether, 0.8 mmol) were added (active catalyst is indicated by the reaction solution turning orange). The septum was replaced with a TefIonC~-lined screw cap under an inert atmosphere and the reaction stirred at RT or warmed to 60 or 70°C until complete. After this time, the mixture was diluted with a suitable organic solvent (15 mL) and washed successively with 1 M Na3EDTA solution (prepared from EDTA and 3 equiv of NaOH), water and brine. After drying (anhydrous MgS04) the solution was filtered, the solvent removed in vacuo, and the residue purified by flash chromatography.
A summary of the substrate scope that was explored is presented in Table 8.
Example 15: Enolate Arylation General procedure: In air a vial was charge with Ih or Ik (1 mol%, 6 mg), sodium tert butoxide (1.5 mmol, 1.44 mg) the vial was then purged with Ar.
After which toluene (1 mL), ketone (1.1 mmol) and the aryl chloride (1.0 mmol) were added in turn and sealed with a screw cap. The vial was then placed in an oil bath at 60°C and the mixture stirred on a stirring plate. When reaction reached completion, or no further conversion could be observed by TLC, the vial was allowed to cool to room temperature. Water was added to the reaction mixture; the organic layer was extracted with diethyl ether and dried over magnesium sulfate. The solvent was then evaporated in vacuo and the product purified by column chromatography.
Representative Example:
o cv o ~ I
y 24h I
90%
Example 16: Sonogashira Reaction (i) Primary Alkyl Bromides Ih (0.04 Eq) O Cul (0.08 Eq) O
~Br + / Cs2C03 (1.45 Eq) ~
O ~ DMF:DME (1.5W1~ O
1 eq 1.45 eq 83%
A powder of Ih (0.8500 g)/Cul (0.4750 g) was prepared. In air, the Ih/Cul powder (21.2 mg) and Cs2COs (0.7 mmol, 228.0 mg) were added to a vial equipped with a magnetic bar, and sealed with a Teflon~-lined screw cap and fitted with a septum. The vial was purged with Argon, and DMF (1.2 mL) 10 followed by DME (0.8 mL) were added. The contents were allowed to stir at room temperature for 30 min. The alkyl bromide (0.5 mmol, 67 pL), followed by the octyne (0.73 mmol, 110 NL) were added. The vial was then placed in an oil bath at 60°C for 18h. An aqueous workup was performed, the organic layer extracted with pentane and dried over MgS04. The solvent was 15 removed using a rotary evaporator and the product was purified using flash chromatography with 2% ether/pentane eluent, yielding 92.6 mg of the product.
(ii) Secondary Alkyl Bromides Ih (0.05 Eq) Cul (0.10 Eq) / a Br + Cs2C03 (1.45 Eq) DMF:DME (1.86:1) 87%
CH3(CH2)7NH2 (0.2 Eq) q 1.45 eq A powder of Ih(0.8500 g) /Cul (0.4750 g) was prepared. In air, the Ih/Cul powder (26.5 mg) and Cs2C03 (0.7 mmol, 228.0 mg) were added to a vial equipped with a magnetic bar, and sealed with a Teflon~-lined screw cap and fitted with a septum. The vial was purged with Argon and DMF (1.3 mL) followed by DME (0.7 mL) were added. The contents were allowed to stir at room temperature for 30 min. The octylamine (20 mol%,16.5 NL) was added at the end of the stirring time followed by the alkyl bromide (0.5 mmol, 67 NL), followed by the octyne (0.73 mmol, 110 NL). The vial was then placed in an oil bath at 60°C for 18h. An aqueous workup was performed, the organic layer extracted with pentane and dried over MgS04. The solvent was removed using a rotary evaporator and purified using flash chromatography with hexane eluent. 90.3 mg of the product, determined by NMR, was isolated.
Example 17: Bis Pinicol 8orane In air, a vial was charged with Ih (10.2mg, 0.015mmol, 3mol%), bis(pinacolato)diboron (0.1397g, 0.55mmol) and KOAc (0.147g, 1.5mmol).
The vial was sealed and purged with argon. Bromobenzene (52pL, 0.5mmol) and 3mL of DMSO were then added. The resulting mixture was then stirred at 90°C until the reaction was complete. The product was extracted into ether, separated and dried over MgS04. The product was purified by column chromatography. Results for various substrate scope and reaction conditions are presented in Table 9.
While the present invention has been described with reference to what are presently considered to be the preferred examples, it is to be understood that the invention is not limited to the disclosed examples. To the contrary, the invention is intended to cover various modifications and equivalent arrangements included within the spirit and scope of the appended claims.
All publications, patents and patent applications are herein incorporated by reference in their entirety to the same extent as if each individual publication, patent or patent application was specifically and individually indicated to be incorporated by reference in its entirety. Where a term in the present application is found to be defined differently in a document incorporated herein by reference, the definition provided herein is to serve as the definition for the term.
TABLE 1: CATALYTIC ACTIVITY OF THE NHC-PD COMPLEXES Ih, Ij AND
Ii IN ALKYL-ALKYL CROSS-COUPLING REACTIONS
entry M yield of n-heptylbenzenea 1 ZnBr~ 100 % (1h), 34 % (1j), 8.0 % (Ii) 2 BBu2" 100 % (1h), 31 % (1j), 6.5 % (II) 3 MgBre 100l0 (1h) aGC yield (internal standard-undecane) after 24 hours at room temperature;
all reactions in duplicate. bGontrol experiments with no catalyst showed no conversion in all cases. ~n-Butylzinc bromide (1.3 equiv), THF-NMP = 2:1. dtri-n-butylborane (1.2 equiv), f-BuOK (1.3 equiv), i-PrOH. Bn-Butyl magnesium bromide (1.5 eq), 1-chloro-3-phenylpropane used instead of 1-bromo-3-phenylpropane, THF:DMI = 2:1, RT, 45 min.
TABLE 2. OPTIMIZATION OF SUZUKI CONDITIONS FOR BORONIC ACIDS
entryacatalyst solvent base temp. yield (%) (mol %) (Equiv) (C) 1 Ii (2) Dioxane Cs2C03 80 74 (2) 2 Ij (2) Dioxane Cs2C03 80 95 (2) 3 Ij (2) DME Cs2C03 80 54 (2) 4 Ih (2) Dioxane K3P04 (2) 80 48 Ih (2) Dioxane Cs2C03 80 92 (2) 6 Ih (2) DME Cs2C03 80 77 (2) 7 Ih (2) Dioxane K2C03 (2) 80 80 8 Ih (2) Dioxane K2C03 (3) 80 95 9 Ih (2) Dioxane K2COs (3) 60 97 Ih (2) Dioxane K2C03 (3) rt 86 11 Ih (1) Dioxane K2C03 (3) 80 74 12 Ih (1) i-PrOH t-BuOK rt 97 aGC yield (internal standard-undecane) after 2 hours at room temperature; all reactions in duplicate. bControl experiments with no catalyst showed no conversion.
TABLE 3. OPTIMIZATION OF SUZUKI CONDITIONS FOR POTASSIUM
TRIFLUOROBORATES
entry solvent base temp. yield (Equiv) (C) (/)8a 1 Dioxane K2COs (3) 60 0 2 MeOH K2COs (3) 60 90 3 EtOH K2C03 (3) 60 30 4 i-PrOH K2C03 (3) 60 27 5 MeOH K2C03 (3) rt 86 6 MeOH CsF 60 0 7 MeOH KOH 60 91 8 MeOH K3P04 60 84 aGC yield (internal standard-undecane) after 24 hours at room temperature;
all reactions in duplicate. bControl experiments with no catalyst showed no conversion.
TABLE 4. OPTIMIZATION OF SUZUKI CONDITIONS FOR POTASSIUM
TRIFLUOROBORATES USING COMPLEX Ih AS THE CATALYST
Complex Ih RvX + M-R" (1-2 m01%) R,-R"
(1.2 equiv) Method A, B, C or D
rt, 60 degrees Celsius -o I w O \ ../ / \
i (8, 93%, 2h, Method A)a -O
(X = GI, M = B(OH)z) S \ O .,, (10, 93%, 24h Method A)e (X=Br, M=B(OH)z) (9, 88%, 2h, Method A)B
(X = Br, M = B(OH)z) S~N~
N
r ~~ ' (11, 98°r6, 6h, Method C)86 (X=Br,M=BF3K) w w i i w w (12, 85%, 2h, Method A)e ( ~ ~ \
(X = CI, M = B(OH)z) (13, 85%, 2h, Method A)a N
(X = CI, M = B(OH)z) o (14, 96 /o, 2h, Method B) O (X = CI, M = 8(OH)z) NOz O-_ _ S ~ \ /
NC \ / \ / I / I w (16, 99%, 6h, Method B)e (15, 77%, 18h, Method B)a (X = C1, M = B(OH)z) (X = CI, M = B(OH)z) w w i i / \ O/ (1 ~X97oBr. Mh~ B(OH)d)O)a O
O ~H
\ / \
18, 60%, 6h, Method B)e {X = CI, M = B(OH)z) O
\ N-N
O i v \~/
O
(19, 93%, 16h, Method B)a° (20, 92%, 6h, Method C)e {X = Br, M = B(OH)z) (X = CI, M = BF3K) aAll reactions were erformed using standard laboratory technique, i.e. no glove-box was employed: Method ~: Ih (1 mol/o , KOBu (1.3 a uiv.), reagent grade iso ropanol, room temperature. Method B: Ih (2 mola/°), dioxane, 60°~ . Method C:
Ih (2 mold/°~ KZC03 (3.0 eqmv.), methanol, 60°C. Method D: Ih (2 mol%), KOHS (3.0 aquiv.), dioxane, rt. Yielded 70%
after 12h at rt. °Using Ih (4 mol%) K2C03 (6.0 equiv) and RB(OH2) (2.4 equiv).
TABLE 5. EVALUATION OF COMPLEX Ih IN THE NEGISHI REACTION
Complex Ih (1 mol%) R'-X + R~~-ZnBr/CI R~-R"
(1.6 equiv) Solvent rt, 24h Entry R~ X R~ Yield (%
1 Ph(CH2)3CI nBu~b~9~ f a~
2 Ph(CH2)3Br nBu~'9'"~100 3 Ph(CHZ)3I nBu~'~9~ 68 4 Ph(CHZ)3OTs nBu~~9~ 100 5 Ph(CHZ)3OMs nBu~~9~ 100 6 Ph CI nHeptyl~d~9~100 7 Ph Br nHeptyl~b~9~100 8 Ph I nHeptyl~d~9~95 9 Ph OTf nHeptyl~d~9~100 10 Ph OMs nHeptyl~d~9~0 11 Ph OTs nHeptyl~d~9~0 12 nHeptylCI Phlf~9 70 13 nHeptylBr Ph~e'9~ 100 14 nHeptylI Ph~f~9~ 100 15 nHeptylOTs Ph~f'9~ 90 16 nHeptylOMs Phlf'9~ 87 17 pT0lyl CI pM20CsH4~e~80 18 pTOlyl Br pMeOCsH4~e~88 19 pTolyl I pMeOCsH4~e~73 20 pT0lyl OTf pMeOC6H4~e~71 21 pTOlyl OMS pM20CsH4~e~0 22 ~ pTolyl OTs pMeOC6H4~e~0 ~ ~
TABLE 5. EVALUATION OF COMPLEX Ih IN THE NEGISHf REACTION
(CONTINUED) [a] GC yield against calibrated internal standard (undecane) performed in duplicate. (b] THF:DMI, 2:1. [c] THF:DMI, 1:3. [d] THF:DMI, 1:2, [e] THF:NMP, 2:1. [f] THF:NMP, 1:2. (g] Liar or LiCI (2 equiv relative to the organozinc reagent) was added. [h] Yield 63% after 24 hours with a catalyst loading of 0.1 mol%
TABLE 6. EVALUATION OF COMPLEX Ih IN THE NEGISHI REACTION:
SUBSTRATE SCOPE
Complex Ih (1 mol%) R'-X + R"-ZnBr/CI R~-R"
(1.6 equiv) THF/NMP or THF/DMI
rt to 60 degrees Celsius, 2h sPs_sl~
O CI 'CN
I / 'N 21, 81 %, X=Br, rt p 22, 80%, X=Br, rt O
v W, O ~O I
Calcd.
for C32H4oC13NsPd: C, 56.57; H, 5.93; N, 6.18. Found: C, 56.90; H, 5.99; N, 6.52.
(ii) The above reaction for the preparation of complex Ih was repeated using other bases. The percent yield of Ih was as follows:
Na2C03 - 98%
K2C03 - 97%
K3POs - 43%
CaC03- 25%
Cs2C03- 93%
NaOAc- 60%
It should be noted that reactions performed in the absence of base did not provide optimum amounts of desired products.
(iii) The number of equivalents of base in the above reactions was also varied, with the following results:
2 equiv NaOAc - 60% compound Ih 2 equiv K2C03 - 80% compound Ih 1.25 and 2.5 equiv. Na2COs- 73% compound Ih (iv) Using the general synthesis in part (i) above, the corresponding Pt complex (R = iPr, R' = H) was made in 60% yield using PtCl2 and K2C03 as base.
(v) Using the corresponding saturated version of Ila, compound Ik was also prepared:
R ~ R
N N
R ~ R
CI-Pd-CI
I
N
CI
Ik R = iPr (vi) By replacing 3-chloropyridine with 2-phenyl pyridine, compounds Ip was prepared in 86% using Cs2C02 as base.
iPr iPr ~ I n ~
N N
iPr ~ iPr CI-M
N
Ip Example 2: Catalytic Activity of the NHC-Pd catalysts Ih, Ii and Ij in alkyl-alkyl cross-coupling reactions Pd-NHC catalyst Ih, Ij or 1i Br +
(1 mol%) and nBuZnBr (Negishi) or tri-n-butylborane (Suzuki) Complex Ih (Example 1, 1 mol %) was subjected to standard alkyl-alkyl Suzuki and Negishi cross-coupling reactions. Reaction conditions are provided in Table 1. The reactions were rapid (Suzuki 5 minutes, Negishi 30 minutes). Quantitative formation of the reaction product was observed at room temperature (Table 1 ).
Example 3: Rate studies with complexes Ih and Ij in alkyl-alkyl cross-couplings shown in Example 2 The results of the rate studies with complexes Ih and Ij (see Example 1) in the alkyl-alkyl cross-couplings (a) Suzuki reaction, (b) Negishi reaction are shown in Figure 1. The yields were determined by GC/MS against a calibrated internal standard (undecane). As seen in Figure 1, the rate of the reaction with complex Ij was much slower than with complex Ih. While not wishing to be limited by theory, these results are suggestive that bulky NHC ligands lead to fast reductive elimination, which suppresses undesired side reactions or catalyst decomposition in a manner analogous with bulky phosphines. Since complexes Ih, Ij and Ii are air- and water tolerant and do not decompose upon standing, heating Ih at 100 °C in DMSO-ds for 24 hours led to no visable decomposition (by 'H and '3C NMR spectroscopic analysis). Thus, it is unlikely that pyridine dissociation initiates catalyst activation considering the high stability of complex Ih. Rather, rapid reduction facilitated by the organometallic reagent takes place followed by pyridine dissociation from the generated Pd(0) species (Figure 2).
Example 4: Mechanistic Studies: Activation and use of complex Ih Complex Ih (Example 1 ) was treated with 2 equivalents of n-heptylzinc bromide and the reaction mixture was analyzed by GC/MS. From this analysis, the formation of n-tetradecane and liberation of 3-chloropyridine was observed. DFT calculations at the B3LYP/DZVP level showed that the binding enthalpy of 3-chloropyridine to NHC-ligated Pd(II) is 4.5 kcal mol-~ higher than to Pd(0). Also the dissociation energy of PH3 is 16.5 kcal mol-1 compared to 19.4 kcal mol-~ for the 3-chloropyridine.
Example 5: Comparison between in situ catalyst and NHC-PdCl2-3-chloropyridine (Ih) complexes in the alkyl-alkyl Negishi reaction A significant increase in rate was observed when catalysis with complex Ih (Example 1) at 1 mol % was compared to the prior art Pd2(dba)3/Ila in situ protocol at 4 mol % (Figure 3a). Due to extremely fast rates at 1 mol % of Ih, it was not possible to reliably measure the reaction rate, therefore, a loading of 0.1 mol % was used (Figure 3b). A comparison with the in situ protocol is shown after 1 hour. Given that both reactions were 30 % complete at that time, the apparent (turnover numbers) TONs suggest, assuming the same 5 active catalyst is generated when employing the in situ protocol, that only 0.1 mol % of active catalyst is actually formed, even though 4 mol % of the precursors are used. !t should be pointed out that, in the prior art Pd2(dba)3/Ila in situ protocol, the catalysis was weighed in a glove box, taking great care to avoid contact with air and water. Using the compounds of formula I of the 10 present invention, the catalyst (or precatalyst) could be weighed in the open with no special precautions to avoid contact with air. The advantages in reaction time and yield when the compounds of formula I are used in the metal-catalyzed cross-coupling reaction are clearly seen in the graphs shown in Figure 3.
Example 6: Optimization of Suzuki conditions for boronic acids CI B(OH)2 Pd-NHC catalyst Ih, ij or Ii ~. OMe (1-2 mol%) i Solvent/Base OMe Temperature (degrees Celsius) Complexes Ih, Ij or Ii was subjected to a variety of Suzuki reaction conditions (Table 2). It was found that all complexes functioned as excellent catalysts at 80 °C. !n comparison to complexes Ij and Ii, it was found that complex !h was advantageous as it was possible to conduct reactions in both dioxane and i PrOH at room temperature with a judicious choice of base (Table 2, entries, 10 and 12).
Example 7: Optimization of Suzuki conditions for potassium trifluoroborates Pd-NHC catalyst Ih / OMe (2 mol%) Solvent/Base OMe Temperature (degrees Celsius) Expansion of the protocol in Example 6 to potassium trifloroboroates was accomplished by simply changing the solvent to methanol (Table 3, entries 2, 5, 6-8).
Example 8: Suzuki cross-coupling reactions substrate scope There are 4 different protocols for this reaction dependent on the coupling partners. Robust functionality can be coupled at room temperature in isopropyl alcohol (IPA) using KOt-Bu as base, while base-sensitive groups may be coupled utilizing K2COs at 60°C. For relatively hindered substrates sensitive to KOt-Bu and where K2C03 is ineffective, KOH may be used at room temperature. Optimal to the success is ensuring that the precatalyst is activated. When utilizing KOt-Bu, a change in reaction solution color, normally to orange or red, is observed. When utilizing K2C03 or KOH, in the absence of strongly colored materials the reaction is generally complete when the solution is grey in color and contains noticeable precipitate.
The employment of a variety of reaction conditions allowed a large array of hindered biaryls and drug-like heteroaromatics to be easily synthesized using Suzuki cross-coupling reaction conditions (Table 4). A notable example is the synthesis of 19 (Table 4), which when used in combination with triethylphosphine has been demonstrated to form a highly effective asymmetric Morita-Baylis-Hillman (MBA) protocol [McDougal, N.T.; Schaus, S.E. J. Am. Chem. Soc. (2003) 125, 12094-12095]. Methods A, B, C and D
are described in detail below. Use of IPA/t-BuOK (Method A) allowed for rapid cross-coupling at room temperature whereas more sensitive coupling partners were effectively coupled utilizing mild K2C03 in dioxane (Method B) or methanol in the case of potassium trifluoroborates (Method C).
(i) Procedure for Method A.
In air, a vial was charged with potassium tert-butoxide (154 mg, 1.30 mmol) and complex Ih (6.8 mg, 0.01 mmol) and the vial was sealed and purged with argon (3x). Technical grade isopropanol (1.0 mL) was added and the contents were stirred at room temperature until a colour change from yellow to red/brown was observed (~10 min). Under a cone of argon, the boronic acid (1.20 mmol) was added, the vial was resealed with a septum and the organohalide (1.00 mmol) injected via microlitre syringe. Alternatively, if the boronic acid was soluble in isopropanol, it was added as a solution (1.0 mL).
The solution was stirred at room temperature for the indicated period of time.
The reaction was then diluted with diethyl ether (2 mL) and transferred to a round bottom flask. The reaction vial was rinsed with additional diethyl ether (2 mL) and combined with the previous dilution. Each reaction was performed in duplicate and the contents were combined, concentrated onto silica gel and purified by flash chromatography.
(ii) Procedure for Method B.
In air, a vial was charged with complex Ih (6.8 mg, 0.01 mmol), potassium carbonate (207 mg, 1.50 mmol), the boronic acid (0.6 mmol) and the organohalide (0.5 mmol). The vial was sealed with a septum and purged with argon (3X). Dioxane (2.0 mL) was added and the contents were stirred at 60°C for the specified period of time. The reaction was then diluted with diethyl ether (2 mL) and transferred to a round bottom flask. The reaction vial was rinsed with additional diethyl ether (2 mL) and combined with the previous dilution. Each reaction was performed in duplicate and the contents were combined, concentrated onto silica gel and purified by flash chromatography.
(iii) Procedure for Method C.
In air, a vial was charged with complex Ih (6.8 mg, 0.01 mmol), potassium carbonate (207 mg, 1.50 mmol), the potassium trifluoroborate (0.55 mmol) and the organohalide (0.5 mmol). The vial was sealed with a septum and purged with argon (3x). Technical grade methanol (2.0 mL) was added and the contents stirred at 60°C for the specified period of time. The reaction was then diluted with diethyl ether (2 mL) and transferred to a round bottom flask.
The reaction vial was rinsed with additional diethyl ether (2 mL) and combined with the previous dilution. Each reaction was performed in duplicate and the contents were combined, concentrated onto silica gel and purified by flash chromatography.
(iv) Procedure for Method D.
Method B was followed however in the place of solid potassium carbonate, solid KOH (84 mg, 1.50 mmol) was utilized. Additionally, the reaction was carried out at room temperature instead of 60°C.
Example 9: Evaluation of Complex Ih in the Negishi reaction A comprehensive evaluation of complex Ih in the Negishi cross-coupling reaction was performed. The results presented in Table 5 demonstrate that complex Ih was able to catalyze the cross-coupling of organo-chlorides, bromides and iodides, aryl triflates and alkyl tosylates and mesylates in all possible pairings of potential cross-coupling substrates, including all possible hybridization states of the atoms specifically involved in the coupling, in high yield at room temperature (Table 5, entries 1-3, 6-8, 12-14 and 17-19).
There were 4 main protocols for this reaction dependant on organohalide and carbon hybridization present in the coupling partners. Whilst most reactions are carried out at room temperature, sterically encumbered partners were optimally warmed to 60-70°C to ensure efficient cross-coupling.
Furthermore, the addition of 2 equivalents (based on organozinc) of Liar or LiCI (available from Aldrich as 1 M anhydrous solutions in THF or DMI) is important to effect cross-coupling in some reaction types (see Protocols below). Efficient catalyst formation and reaction is normally indicated by a slow color change from pale yellow to a deep brown-colored solution when employing zinc made by the Hou protocol in DMI (Org. Lett. 2003, 5, 423). If this change is rapid, (1-2 seconds) this is indicative of a failed reaction and is normally the result of ineffective catalyst activation, which could be due to the steric and/or electronic properties of the organozinc reagent. Use of organozincs formed by Rieke zinc does not show the same color change. Additionally, the use of n-BuLi for formation of aryl zincs should be avoided as the generated butyl halide is a capable coupling partner for complex Ih due to its high reactivity.
Cross-Coupling Procedures: All cross-coupling reactions were run with a final solvent volume of 2.4 mL.
Solvent ratios Alkyl bromides: DMI/NMP: THF, 1:2 Alkyl chlorides, iodides, tosylates and mesylates: DMI/NMP: THF, 3:1 Aryl bromides: DMI/NMP: THF, 1:2 Aryl chlorides, triflates: DMI/NMP:THF, 3:1 (sp3X-sp3ZnX): A vial was charged with Ih (3.4 mg, 1 mol%), Liar (139.0 mg, 1.6 mmol, transferred under a filter cone flowing with inert gas) and a stirbar, after which it was sealed with a septum and purged under an inert atmosphere. THF (X mL) and DMI (X mL) or NMP (X mL) were then added and the suspension stirred until the solids dissolved after which the organozinc (0.8 mL, 1.0 M in DMI or NMP, 0.8 mmol) and the organohalide or pseudo halide (0.5 mmol) were added. The septum was replaced with a Teflon-lined screw cap under an inert atmosphere (e.g. under a cone of argon, not necessarily in a glove box) and the reaction stirred for 2h. After this time, the mixture was diluted with ether (15 mL) and washed successively with 1 M Na3EDTA solution (prepared from EDTA and 3 equiv of NaOH), water and brine. After drying (anhydrous MgSOa) the solution was filtered, the solvent removed in vacuo, and the residue purified by flash chromatography.
(sp3X-sp2ZnX): A vial was charged with Ih (3.4 mg, 1 mol%) and under an inert atmosphere ZnCl2 (107 mg, 0.8 mmol, transferred under a filter cone flowing with inert gas) and a stirbar were added. The vial was then sealed with a septum and purged under an inert atmosphere. THF (0.8 mL) was added followed by the requisite Grignard reagent (0.8 mL, 1.0 M in THF, 0.8 mmol) and stirring continued for 15 minutes at which time a white precipitate formed.
Under an inert atmosphere, Liar (139.0 mg, 1.6 mmol), NMP (0.8 mL) or DMI
(0.8 mL) and the organohalide or psuedo halide (0.5 mmol) were added. The septum was replaced with a Teflon-lined screw cap under an inert atmosphere and the reaction stirred for 2h. After this time, the mixture was diluted with ether (15 mL) and washed successively with 1 M Na3EDTA
5 solution (prepared from EDTA and 3 equiv of NaOH), water and brine. After drying (anhydrous MgS04) the solution was filtered, the solvent removed in vacuo, and the residue purified by flash chromatography.
(sp2X-sp3ZnX): A vial was charged with Ih (3.4 mg, 1 mol%), Liar (139.0 mg, 1.6 mmol, transferred under a filter cone flowing with inert gas) and a stirbar 10 after which it was sealed with a septum and purged under an inert atmosphere. THF (X mL) and DMI (X mL) or NMP (X mL) were then added and the suspension stirred until the solids dissolved after which the organozinc (0.8 mL, 1.0 M in DMI or NMP, 0.8 mmol) and the organohalide or psuedo halide (0.5 mmol) were added. The septum was replaced with a 15 TefIonC~-lined screw cap under an inert atmosphere and the reaction stirred for 2h. After this time, the mixture was diluted with ether (15 mL) and washed successively with 1 M Na3EDTA solution (prepared from EDTA and 3 equiv of NaOH), water and brine. After drying (anhydrous MgS04), the solution was filtered, the solvent removed in vacuo, and the residue purified by flash 20 chromatography.
(sp2X-sp2ZnX): In air, a vial was charged with Ih (3.4 mg, 1 mol%) and ZnCl2 (0.8 mmol, transferred under a filter cone flowing with inert gas) and a stirbar were added. The vial was then sealed with a septum and purged under an inert atmosphere. THF (X mL) was then added followed by the requisite 25 Grignard reagent (0.8 mL, 1.0 M in THF, 0.8 mmol) and stirring continued for 15 minutes at which time a white precipitate formed. NMP (X mL) was then added followed by the organohalide or pseudo halide (0.5 mmol) and the septum was replaced with a Teflon~~-lined screw cap under an inert atmosphere and the reaction stirred for 2h. After this time, the reaction 30 mixture was diluted with ether (15 mL) and washed successively with 1 M
Na3EDTA solution (prepared from EDTA and 3 equiv of NaOH), water and brine. After drying (anhydrous MgS04) the solution was filtered, the solvent removed in vacuo, and the residue purified by flash chromatography.
Example 10: Negishi cross-coupling reactions substrate scope As seen in Table 6, functionalization of the reactants did not diminish the generality of the protocols described in Example 9, with sp3(RX)-sp3(RZnX), spa-sp2, sp2-spa and sp2-sp2 cross-coupling reactions easily accomplished with 1 mot % complex Ih. Coupling of a range of alkyl bromides, chlorides and tosylates was achieved at room temperature (Table 6, compounds 21-26).
Remarkably, by careful choice of reaction conditions it was possible to selectively couple a bromide in the presence of a chloride (Table 6, compound 21 ). An array of functionality was tolerated including esters, nitrites, amides and acetals (Table 6, 21-26). Noteworthy examples are the coupling of (S)-citronellyl bromide in high yield (Table 6, compound 27) and the stability of the TMS group in the reaction conditions (Table 6, compounds 25, 28 and 29).
The coupling of alkyl zinc reagents with aryl halides or aryl triflates occurred in high yield with no transmetalation to the aryl zinc observed (Table 6, compounds 31-34). Aryl halides, as expected, proved to be excellent coupling partners. Accordingly, the facile synthesis of a range of drug-like heteroaromatics and sterically congested biaryls was accomplished in high yield (Table 6, compounds 35-41 ). A significant entry is the coupling of o-chlorotoluene and 2,4,6-triisopropylphenylzinc chloride at 60 °C (Table 6, compound 35). N-Boc protected indole, pyridine, and multiple heteroatom containing heterocycles were well tolerated (Table 6, compounds 31, 32, 34, 37, 39-41) Finally, the cross-coupling of a chiral zinc reagent with an acyl chloride (Table 6, compound 33) proceeded Without concomitant decarbonylation, demonstrating the mildness of this protocol.
Example 11: Heck cross-coupling reaction Br O O' \
O' \ W
A vial was charged with complex Ih (17.0 mg, 0.025 mmol, 5 mol%) as defined in Example 1, Cs2C03 (326 mg, 1.0 mmol) and a stir bar. The air was replaced with an inert gas (Ar) and dry DMA was introduced, followed by bromobenzene (53 pL, 78.5 mg, 0.5 mmol), tert-butyl acrylate (117 NL, 103 mg, 0.8 mmol) and n-undecane (GC internal standard, 50 NL). The reaction was stirred at 120°C for 18 hours, then cooled to room temperature, diluted with hexane and analyzed by GC/MS after passing through a short pad of silica gel. Quantitative conversion to (E)-tent butyl cinnamate was observed by GC/MS. GC retention time and EI fragmentation pattern were identical to commercially available material (Aldrich).
Example 12: Buchwald Hartwig coupling reaction C~
o C~
In air, potassium tent-butoxide (127 mg, 1.10 mmol) and complex Ih (6.8 mg, 0.01 mmol, 1.0 mol%) as defined in Example 1 were weighed into a vial with a stir bar and the vial was capped with a septum. The atmosphere was replaced With inert gas (Ar) and 1 mL of dry DME added and stirred until all the solids had dissolved. Chlorobenzene (102 pL, 112.56 mg, 1.0 mmol) and morpholine (96 pL, 96 mg, 1.10 mmol) were then added in quick succession with rapid stirring. The septum was then replaced with a Teflon~ lined cap under inert gas (Ar) and the vial heated at 50°C for 1 hour. After this time the reaction mixture was cooled and partitioned between water and ether, the organic phase was dried (anhydrous MgS04), filtered, and the solvent removed. The resultant residue was purified by flash chromatography eluting with 9:1 pentane:ether. N-Phenylmorpholine was obtained as a white solid 155 mg, 95% yield.
Example 13: Buchwald-Hartwig coupling reactions substrate scope H R,.
Ar-X + ' N-Ar R, ~ N ~ R" R,r A study of the Buchwald-Hartwig coupling reaction substrate scope was performed and the results are shown in Table 7. The general experimental conditions were as follows:
A vial was charged with Ih (14 mg, ~2 mol°l°), KOt-Bu (135.0 mg, 1.2 mmol corrected for purity) and a stirbar were added after which it was sealed with a septum and purged with an inert atmosphere. The amine (1.1 mmol) and organohalide (1.0 mmol) were added and stirred rapidly for 1-2 min. When using 2,6-diisopropylaniline the reaction turns orange immediately; stirring should continue until the solution becomes dark orange to red (note: a green to dark green solution indicates a failure to form sufficient active catalyst).
After this time, DME (1 mL) was added and the septum was replaced with a Teflon-lined screw cap under an inert atmosphere and the reaction stirred at RT or 50°C until complete. After this time, the mixture was diluted with TBME
(15 mL) and washed with water. After drying (anhydrous Na2S04, the use of MgS04 can be problematic), the solution was filtered, the solvent removed in vacuo, and the residue purified rapidly by flash chromatography and stored under an inert atmosphere. Pre-absorption of the crude amine product onto silica should be avoided as this practice has been found to lead to poor recovery.
Example 14: Kumada Reaction Effective coupling partners are aryl chlorides and bromides. Simple couplings can be done at room temperature without the addition of LiCI; if this proves unproductive, heating at 60 or 70°C normally facilitates the cross-coupling. If these conditions fail for challenging partners, 2 or 3 equivalents (based on organomagnesium reagent) of anhydrous LiCI may be added and the reaction temperature varied from RT to 70 °C.
A vial was charged with Ih (7 mg, 2 mol%) and LiCI (67.0 mg, 1.6 mmol) as necessary followed by a stirbar under an inert atmosphere. The vial was then sealed with a septum and purged under an inert atmosphere after which DME
(0.8 mL) was added and the suspension was stirred until Ih had dissolved.
After this time, the organohalide (0.5 mmol) and the organomagnesium (0.8 mL, 1.0 M in THF or ether, 0.8 mmol) were added (active catalyst is indicated by the reaction solution turning orange). The septum was replaced with a TefIonC~-lined screw cap under an inert atmosphere and the reaction stirred at RT or warmed to 60 or 70°C until complete. After this time, the mixture was diluted with a suitable organic solvent (15 mL) and washed successively with 1 M Na3EDTA solution (prepared from EDTA and 3 equiv of NaOH), water and brine. After drying (anhydrous MgS04) the solution was filtered, the solvent removed in vacuo, and the residue purified by flash chromatography.
A summary of the substrate scope that was explored is presented in Table 8.
Example 15: Enolate Arylation General procedure: In air a vial was charge with Ih or Ik (1 mol%, 6 mg), sodium tert butoxide (1.5 mmol, 1.44 mg) the vial was then purged with Ar.
After which toluene (1 mL), ketone (1.1 mmol) and the aryl chloride (1.0 mmol) were added in turn and sealed with a screw cap. The vial was then placed in an oil bath at 60°C and the mixture stirred on a stirring plate. When reaction reached completion, or no further conversion could be observed by TLC, the vial was allowed to cool to room temperature. Water was added to the reaction mixture; the organic layer was extracted with diethyl ether and dried over magnesium sulfate. The solvent was then evaporated in vacuo and the product purified by column chromatography.
Representative Example:
o cv o ~ I
y 24h I
90%
Example 16: Sonogashira Reaction (i) Primary Alkyl Bromides Ih (0.04 Eq) O Cul (0.08 Eq) O
~Br + / Cs2C03 (1.45 Eq) ~
O ~ DMF:DME (1.5W1~ O
1 eq 1.45 eq 83%
A powder of Ih (0.8500 g)/Cul (0.4750 g) was prepared. In air, the Ih/Cul powder (21.2 mg) and Cs2COs (0.7 mmol, 228.0 mg) were added to a vial equipped with a magnetic bar, and sealed with a Teflon~-lined screw cap and fitted with a septum. The vial was purged with Argon, and DMF (1.2 mL) 10 followed by DME (0.8 mL) were added. The contents were allowed to stir at room temperature for 30 min. The alkyl bromide (0.5 mmol, 67 pL), followed by the octyne (0.73 mmol, 110 NL) were added. The vial was then placed in an oil bath at 60°C for 18h. An aqueous workup was performed, the organic layer extracted with pentane and dried over MgS04. The solvent was 15 removed using a rotary evaporator and the product was purified using flash chromatography with 2% ether/pentane eluent, yielding 92.6 mg of the product.
(ii) Secondary Alkyl Bromides Ih (0.05 Eq) Cul (0.10 Eq) / a Br + Cs2C03 (1.45 Eq) DMF:DME (1.86:1) 87%
CH3(CH2)7NH2 (0.2 Eq) q 1.45 eq A powder of Ih(0.8500 g) /Cul (0.4750 g) was prepared. In air, the Ih/Cul powder (26.5 mg) and Cs2C03 (0.7 mmol, 228.0 mg) were added to a vial equipped with a magnetic bar, and sealed with a Teflon~-lined screw cap and fitted with a septum. The vial was purged with Argon and DMF (1.3 mL) followed by DME (0.7 mL) were added. The contents were allowed to stir at room temperature for 30 min. The octylamine (20 mol%,16.5 NL) was added at the end of the stirring time followed by the alkyl bromide (0.5 mmol, 67 NL), followed by the octyne (0.73 mmol, 110 NL). The vial was then placed in an oil bath at 60°C for 18h. An aqueous workup was performed, the organic layer extracted with pentane and dried over MgS04. The solvent was removed using a rotary evaporator and purified using flash chromatography with hexane eluent. 90.3 mg of the product, determined by NMR, was isolated.
Example 17: Bis Pinicol 8orane In air, a vial was charged with Ih (10.2mg, 0.015mmol, 3mol%), bis(pinacolato)diboron (0.1397g, 0.55mmol) and KOAc (0.147g, 1.5mmol).
The vial was sealed and purged with argon. Bromobenzene (52pL, 0.5mmol) and 3mL of DMSO were then added. The resulting mixture was then stirred at 90°C until the reaction was complete. The product was extracted into ether, separated and dried over MgS04. The product was purified by column chromatography. Results for various substrate scope and reaction conditions are presented in Table 9.
While the present invention has been described with reference to what are presently considered to be the preferred examples, it is to be understood that the invention is not limited to the disclosed examples. To the contrary, the invention is intended to cover various modifications and equivalent arrangements included within the spirit and scope of the appended claims.
All publications, patents and patent applications are herein incorporated by reference in their entirety to the same extent as if each individual publication, patent or patent application was specifically and individually indicated to be incorporated by reference in its entirety. Where a term in the present application is found to be defined differently in a document incorporated herein by reference, the definition provided herein is to serve as the definition for the term.
TABLE 1: CATALYTIC ACTIVITY OF THE NHC-PD COMPLEXES Ih, Ij AND
Ii IN ALKYL-ALKYL CROSS-COUPLING REACTIONS
entry M yield of n-heptylbenzenea 1 ZnBr~ 100 % (1h), 34 % (1j), 8.0 % (Ii) 2 BBu2" 100 % (1h), 31 % (1j), 6.5 % (II) 3 MgBre 100l0 (1h) aGC yield (internal standard-undecane) after 24 hours at room temperature;
all reactions in duplicate. bGontrol experiments with no catalyst showed no conversion in all cases. ~n-Butylzinc bromide (1.3 equiv), THF-NMP = 2:1. dtri-n-butylborane (1.2 equiv), f-BuOK (1.3 equiv), i-PrOH. Bn-Butyl magnesium bromide (1.5 eq), 1-chloro-3-phenylpropane used instead of 1-bromo-3-phenylpropane, THF:DMI = 2:1, RT, 45 min.
TABLE 2. OPTIMIZATION OF SUZUKI CONDITIONS FOR BORONIC ACIDS
entryacatalyst solvent base temp. yield (%) (mol %) (Equiv) (C) 1 Ii (2) Dioxane Cs2C03 80 74 (2) 2 Ij (2) Dioxane Cs2C03 80 95 (2) 3 Ij (2) DME Cs2C03 80 54 (2) 4 Ih (2) Dioxane K3P04 (2) 80 48 Ih (2) Dioxane Cs2C03 80 92 (2) 6 Ih (2) DME Cs2C03 80 77 (2) 7 Ih (2) Dioxane K2C03 (2) 80 80 8 Ih (2) Dioxane K2C03 (3) 80 95 9 Ih (2) Dioxane K2COs (3) 60 97 Ih (2) Dioxane K2C03 (3) rt 86 11 Ih (1) Dioxane K2C03 (3) 80 74 12 Ih (1) i-PrOH t-BuOK rt 97 aGC yield (internal standard-undecane) after 2 hours at room temperature; all reactions in duplicate. bControl experiments with no catalyst showed no conversion.
TABLE 3. OPTIMIZATION OF SUZUKI CONDITIONS FOR POTASSIUM
TRIFLUOROBORATES
entry solvent base temp. yield (Equiv) (C) (/)8a 1 Dioxane K2COs (3) 60 0 2 MeOH K2COs (3) 60 90 3 EtOH K2C03 (3) 60 30 4 i-PrOH K2C03 (3) 60 27 5 MeOH K2C03 (3) rt 86 6 MeOH CsF 60 0 7 MeOH KOH 60 91 8 MeOH K3P04 60 84 aGC yield (internal standard-undecane) after 24 hours at room temperature;
all reactions in duplicate. bControl experiments with no catalyst showed no conversion.
TABLE 4. OPTIMIZATION OF SUZUKI CONDITIONS FOR POTASSIUM
TRIFLUOROBORATES USING COMPLEX Ih AS THE CATALYST
Complex Ih RvX + M-R" (1-2 m01%) R,-R"
(1.2 equiv) Method A, B, C or D
rt, 60 degrees Celsius -o I w O \ ../ / \
i (8, 93%, 2h, Method A)a -O
(X = GI, M = B(OH)z) S \ O .,, (10, 93%, 24h Method A)e (X=Br, M=B(OH)z) (9, 88%, 2h, Method A)B
(X = Br, M = B(OH)z) S~N~
N
r ~~ ' (11, 98°r6, 6h, Method C)86 (X=Br,M=BF3K) w w i i w w (12, 85%, 2h, Method A)e ( ~ ~ \
(X = CI, M = B(OH)z) (13, 85%, 2h, Method A)a N
(X = CI, M = B(OH)z) o (14, 96 /o, 2h, Method B) O (X = CI, M = 8(OH)z) NOz O-_ _ S ~ \ /
NC \ / \ / I / I w (16, 99%, 6h, Method B)e (15, 77%, 18h, Method B)a (X = C1, M = B(OH)z) (X = CI, M = B(OH)z) w w i i / \ O/ (1 ~X97oBr. Mh~ B(OH)d)O)a O
O ~H
\ / \
18, 60%, 6h, Method B)e {X = CI, M = B(OH)z) O
\ N-N
O i v \~/
O
(19, 93%, 16h, Method B)a° (20, 92%, 6h, Method C)e {X = Br, M = B(OH)z) (X = CI, M = BF3K) aAll reactions were erformed using standard laboratory technique, i.e. no glove-box was employed: Method ~: Ih (1 mol/o , KOBu (1.3 a uiv.), reagent grade iso ropanol, room temperature. Method B: Ih (2 mola/°), dioxane, 60°~ . Method C:
Ih (2 mold/°~ KZC03 (3.0 eqmv.), methanol, 60°C. Method D: Ih (2 mol%), KOHS (3.0 aquiv.), dioxane, rt. Yielded 70%
after 12h at rt. °Using Ih (4 mol%) K2C03 (6.0 equiv) and RB(OH2) (2.4 equiv).
TABLE 5. EVALUATION OF COMPLEX Ih IN THE NEGISHI REACTION
Complex Ih (1 mol%) R'-X + R~~-ZnBr/CI R~-R"
(1.6 equiv) Solvent rt, 24h Entry R~ X R~ Yield (%
1 Ph(CH2)3CI nBu~b~9~ f a~
2 Ph(CH2)3Br nBu~'9'"~100 3 Ph(CHZ)3I nBu~'~9~ 68 4 Ph(CHZ)3OTs nBu~~9~ 100 5 Ph(CHZ)3OMs nBu~~9~ 100 6 Ph CI nHeptyl~d~9~100 7 Ph Br nHeptyl~b~9~100 8 Ph I nHeptyl~d~9~95 9 Ph OTf nHeptyl~d~9~100 10 Ph OMs nHeptyl~d~9~0 11 Ph OTs nHeptyl~d~9~0 12 nHeptylCI Phlf~9 70 13 nHeptylBr Ph~e'9~ 100 14 nHeptylI Ph~f~9~ 100 15 nHeptylOTs Ph~f'9~ 90 16 nHeptylOMs Phlf'9~ 87 17 pT0lyl CI pM20CsH4~e~80 18 pTOlyl Br pMeOCsH4~e~88 19 pTolyl I pMeOCsH4~e~73 20 pT0lyl OTf pMeOC6H4~e~71 21 pTOlyl OMS pM20CsH4~e~0 22 ~ pTolyl OTs pMeOC6H4~e~0 ~ ~
TABLE 5. EVALUATION OF COMPLEX Ih IN THE NEGISHf REACTION
(CONTINUED) [a] GC yield against calibrated internal standard (undecane) performed in duplicate. (b] THF:DMI, 2:1. [c] THF:DMI, 1:3. [d] THF:DMI, 1:2, [e] THF:NMP, 2:1. [f] THF:NMP, 1:2. (g] Liar or LiCI (2 equiv relative to the organozinc reagent) was added. [h] Yield 63% after 24 hours with a catalyst loading of 0.1 mol%
TABLE 6. EVALUATION OF COMPLEX Ih IN THE NEGISHI REACTION:
SUBSTRATE SCOPE
Complex Ih (1 mol%) R'-X + R"-ZnBr/CI R~-R"
(1.6 equiv) THF/NMP or THF/DMI
rt to 60 degrees Celsius, 2h sPs_sl~
O CI 'CN
I / 'N 21, 81 %, X=Br, rt p 22, 80%, X=Br, rt O
v W, O ~O I
23, 86%, X=Br, rt v v v v v 'pEt I
24, 87%, X=Br, rt I y TMS~
CN
CN
26, 70%, X=OTs, rt 25, 74%, X=CI, rt sPs_s~
O~
v v TMS I i 27, 87%, X=Br, rt 28, 89%, X=CI, rt O~
TMS I / I , I , 'F
29, 92%, X=CI, rt 30, 91 %, X=OTs, rt TABLE 6. EVALUATION OF COMPLEX Ih IN THE NEGISHI REACTION:
SUBSTRATE SCOPE (CONTINUED) sP2_sPs O I ~ O
NC I % ~ N OEt O
31, 81%, X=OTf, rt 32, 98%, X=CI, rt F Et0 i I vv I o I i o tBu-o 0 33, 87%, X=CI, rt 34, 83%, X=Br, rt TABLE 6. EVALUATION OF COMPLEX Ih IN THE NEGISHI REACTION:
SUBSTRATE SCOPE (CONTINUED) sp2-sp2 ~I
v o ~I ° I
35, 90 /°, X=CI, 60 degrees Celsius I
I i I
38, 96%, X=Br, rt 36, 89%, X=CI, 60 degrees Celsius Ph N=N
37, 96%, X=CI, rt F
SN~ I \ \ / I \ > ~ \N"CN
~N~ ~ ~ ~ p 39, 90%, X=Br, rt 40, 98%, X=OTf, rt 41, 90%, X=CI, rt TABLE 7. EVALUATION OF COMPLEX Ih IN THE BUCHWALD-HARTWIG
REACTION: SUBSTRATE SCOPE
Ar-X + R~-NH(R~) R(R~)N-Ar X= CI, Br, I, pTf ~ ,2 Equiv cF3 0 ~o I / I \ N\ NJ
N N '' O~ /
60%, rt, 24hrs 87% rt, 24hrs 92°~0, rt, 24hrs CI Cl, Sodium tort-butixide Cl H
\ N
N ~ ~~~ \ N
H
~/
78% tt, 24 hrs 83%, rt, 24hrs 90%, rt 24hrs Cl, Sodium-tort-butoxide CI Cl, Sodium-ter-t-butoxide I
O
I
~N / I \ \
/ N ~--N N _ ._/
H
87%, rt, 24hrs ~ ~ /
Cl 88%, 50°C, 24hrs Cl, Sodium tert-butoxide 96%, 50°C, 48hrs Cl, Sodium tort-butoxide w y wN~ O
i ~N
N
NH ~ .N NJ
s N °
~ ' ~ N\N, , /
45%, rt, 24hrs 70%, 80°C, 24 C1 37°~0, 50°C, 24hrs hrs, CI, CszC:03 Cl, Sodium tent-butoxide TABLE 8. EVALUATION OF COMPLEX Ih IN THE KUMADA REACTION:
SUBSTRATE SCOPE
X M9X ~ \
I ~ + ~ - R,~ i C~ ~ \\
Ri ~Rz \Rz X= CI, Br, I, OTf 1.3-2.4 Equiv OH
\ / \ \ N, \ Ns ~ / ~ ~ ~ ~N~ I , N__ N ~/ I/
/
85% 95% 96% \
70°,°
I
~.o N ~~ /
N I ~ ~ 'S / \
\ / N I/
/ \ N
I / 87%
.N
90% ~ \ .N
g ,~ i0 ,,- / W
"' \ ( 79%
65%
91% O
~O 83%
\ \
\ I c1 / I N ( / w ( /
77%
81% .N ~J , / N
N SOZPh /
~N~ >99%
/
83%
>99%
TABLE 9: BIS-PINICOL BORANE REACTION RESULTS
+ (X r Br) ~ Ar B O
O O \ O
EntryProduct a~~- Catalyst~~~SolventTime Yield[%f ~ m ~ a~ ~~M
mol ~
i ~
O
i ~
O
B'O
i 4 2 DMSO 15 min 36 ~
i ~
O
w B.O
' ~i NC~
TABLE 9 (Continued) Entry Product Catalyst Solvent Time Yield (%f a~
mol 6 ~ 3 DMSO 20 58 O
B'O
i a 7 ~ 3 DMSO 19 65 O
~ B'o OzN
8 ~ 3 DMSO 42 57 O
i aYield is reported on material that has been purified by flash chromatography on silica gel.
CN
CN
26, 70%, X=OTs, rt 25, 74%, X=CI, rt sPs_s~
O~
v v TMS I i 27, 87%, X=Br, rt 28, 89%, X=CI, rt O~
TMS I / I , I , 'F
29, 92%, X=CI, rt 30, 91 %, X=OTs, rt TABLE 6. EVALUATION OF COMPLEX Ih IN THE NEGISHI REACTION:
SUBSTRATE SCOPE (CONTINUED) sP2_sPs O I ~ O
NC I % ~ N OEt O
31, 81%, X=OTf, rt 32, 98%, X=CI, rt F Et0 i I vv I o I i o tBu-o 0 33, 87%, X=CI, rt 34, 83%, X=Br, rt TABLE 6. EVALUATION OF COMPLEX Ih IN THE NEGISHI REACTION:
SUBSTRATE SCOPE (CONTINUED) sp2-sp2 ~I
v o ~I ° I
35, 90 /°, X=CI, 60 degrees Celsius I
I i I
38, 96%, X=Br, rt 36, 89%, X=CI, 60 degrees Celsius Ph N=N
37, 96%, X=CI, rt F
SN~ I \ \ / I \ > ~ \N"CN
~N~ ~ ~ ~ p 39, 90%, X=Br, rt 40, 98%, X=OTf, rt 41, 90%, X=CI, rt TABLE 7. EVALUATION OF COMPLEX Ih IN THE BUCHWALD-HARTWIG
REACTION: SUBSTRATE SCOPE
Ar-X + R~-NH(R~) R(R~)N-Ar X= CI, Br, I, pTf ~ ,2 Equiv cF3 0 ~o I / I \ N\ NJ
N N '' O~ /
60%, rt, 24hrs 87% rt, 24hrs 92°~0, rt, 24hrs CI Cl, Sodium tort-butixide Cl H
\ N
N ~ ~~~ \ N
H
~/
78% tt, 24 hrs 83%, rt, 24hrs 90%, rt 24hrs Cl, Sodium-tort-butoxide CI Cl, Sodium-ter-t-butoxide I
O
I
~N / I \ \
/ N ~--N N _ ._/
H
87%, rt, 24hrs ~ ~ /
Cl 88%, 50°C, 24hrs Cl, Sodium tert-butoxide 96%, 50°C, 48hrs Cl, Sodium tort-butoxide w y wN~ O
i ~N
N
NH ~ .N NJ
s N °
~ ' ~ N\N, , /
45%, rt, 24hrs 70%, 80°C, 24 C1 37°~0, 50°C, 24hrs hrs, CI, CszC:03 Cl, Sodium tent-butoxide TABLE 8. EVALUATION OF COMPLEX Ih IN THE KUMADA REACTION:
SUBSTRATE SCOPE
X M9X ~ \
I ~ + ~ - R,~ i C~ ~ \\
Ri ~Rz \Rz X= CI, Br, I, OTf 1.3-2.4 Equiv OH
\ / \ \ N, \ Ns ~ / ~ ~ ~ ~N~ I , N__ N ~/ I/
/
85% 95% 96% \
70°,°
I
~.o N ~~ /
N I ~ ~ 'S / \
\ / N I/
/ \ N
I / 87%
.N
90% ~ \ .N
g ,~ i0 ,,- / W
"' \ ( 79%
65%
91% O
~O 83%
\ \
\ I c1 / I N ( / w ( /
77%
81% .N ~J , / N
N SOZPh /
~N~ >99%
/
83%
>99%
TABLE 9: BIS-PINICOL BORANE REACTION RESULTS
+ (X r Br) ~ Ar B O
O O \ O
EntryProduct a~~- Catalyst~~~SolventTime Yield[%f ~ m ~ a~ ~~M
mol ~
i ~
O
i ~
O
B'O
i 4 2 DMSO 15 min 36 ~
i ~
O
w B.O
' ~i NC~
TABLE 9 (Continued) Entry Product Catalyst Solvent Time Yield (%f a~
mol 6 ~ 3 DMSO 20 58 O
B'O
i a 7 ~ 3 DMSO 19 65 O
~ B'o OzN
8 ~ 3 DMSO 42 57 O
i aYield is reported on material that has been purified by flash chromatography on silica gel.
Claims (33)
1. A compound of the formula I:
wherein R1 and R2 are independently or simultaneously selected from the group consisting of C1-20alkyl, C3-20cycloalkyl, aryl and heteroaryl, said latter 4 groups being optionally substituted and/or one or more of the CH2 groups in C1-20alkyl and/or C3-20cycloalkyl is optionally replaced with a heteroatom selected from the group consisting of O, S, and NR5;
R3 and R4 are independently or simultaneously selected from the group consisting of H, halo, C1-20alkyl, OC1-20alkyl, C3-20cycloalkyl, OC3-20cycloalkyl aryl, O-aryl, heteroaryl and O-heteroaryl, said latter 8 groups being optionally substituted and/or one or more of the CH2 groups in C1-20alkyl, OC1-20alkyl, 20cycloalkyl and/or OC3-20cycloalkyl is optionally replaced with a heteroatom selected from the group consisting of O, S, and NR5;
or R3 and R4 are linked to form an optionally substituted 4 to 12-membered ring system which optionally contains one or more heteroatoms selected from the group consisting of O, S, and NR5;
R5 is selected from the group consisting of H and C1-6alkyl;
is a single or a double bond;
a is 1, 2 or 3;
M is a transition metal;
b is an integer representing the number of the anionic ligands X required to fulfill the valency requirements of M;
X is an anionic ligand and when b is greater than 1, each X may be the same or different;
L is a 5- to 6-membered optionally substituted N-containing aromatic heterocycle coordinated to M through N, which is optionally benzofused, and/or optionally contains one or more other heteroatoms selected from the group consisting of O, S, and NR5, and/or one or more of the optional substituents on the N-containing aromatic heterocycle is bonded to M in place of one or more X;
or L is R6-C=C-R7 in which R7 and R8 are independently or simultaneously selected from the group consisting of C1-20alkyl, OC1-20alkyl, C3-20cycloalkyl, OC3-20cycloalkyl, aryl, O-aryl, heteroaryl and O-heteroaryl, said latter 8 groups being optionally substituted;
one or more of the carbons of the alkyl and cycloalkyl groups of R6 and R7 are optionally replaced with -C(O)-, -C(O)NR5- and -C(O)O-;
aryl is an optionally substituted mono- or polycyclic aromatic radical containing from 6 to 14 carbon atoms;
heteroaryl is a mono- or polycyclic heteroaromatic radical containing from 5 to 14 atoms, of which 1 to 5 atoms may be a heteroatom selected from the group consisting of S, O, N and NR5; and optionally substituted means that one or more of the hydrogens on the group are optionally replaced with halo, OH, C1-6alkyl, OC1-6alkyl, fluoro-substituted C1-6alkyl, fluoro-substituted OC1-6alkyl, aryl or aryl that is substituted with 1-5 substituents independently or simultaneously selected from the group consisting of fluoro, C1-4alkyl, OC1-4alkyl, fluoro-substituted C1-4alkyl and fluoro-substituted OC1-4alkyl.
wherein R1 and R2 are independently or simultaneously selected from the group consisting of C1-20alkyl, C3-20cycloalkyl, aryl and heteroaryl, said latter 4 groups being optionally substituted and/or one or more of the CH2 groups in C1-20alkyl and/or C3-20cycloalkyl is optionally replaced with a heteroatom selected from the group consisting of O, S, and NR5;
R3 and R4 are independently or simultaneously selected from the group consisting of H, halo, C1-20alkyl, OC1-20alkyl, C3-20cycloalkyl, OC3-20cycloalkyl aryl, O-aryl, heteroaryl and O-heteroaryl, said latter 8 groups being optionally substituted and/or one or more of the CH2 groups in C1-20alkyl, OC1-20alkyl, 20cycloalkyl and/or OC3-20cycloalkyl is optionally replaced with a heteroatom selected from the group consisting of O, S, and NR5;
or R3 and R4 are linked to form an optionally substituted 4 to 12-membered ring system which optionally contains one or more heteroatoms selected from the group consisting of O, S, and NR5;
R5 is selected from the group consisting of H and C1-6alkyl;
is a single or a double bond;
a is 1, 2 or 3;
M is a transition metal;
b is an integer representing the number of the anionic ligands X required to fulfill the valency requirements of M;
X is an anionic ligand and when b is greater than 1, each X may be the same or different;
L is a 5- to 6-membered optionally substituted N-containing aromatic heterocycle coordinated to M through N, which is optionally benzofused, and/or optionally contains one or more other heteroatoms selected from the group consisting of O, S, and NR5, and/or one or more of the optional substituents on the N-containing aromatic heterocycle is bonded to M in place of one or more X;
or L is R6-C=C-R7 in which R7 and R8 are independently or simultaneously selected from the group consisting of C1-20alkyl, OC1-20alkyl, C3-20cycloalkyl, OC3-20cycloalkyl, aryl, O-aryl, heteroaryl and O-heteroaryl, said latter 8 groups being optionally substituted;
one or more of the carbons of the alkyl and cycloalkyl groups of R6 and R7 are optionally replaced with -C(O)-, -C(O)NR5- and -C(O)O-;
aryl is an optionally substituted mono- or polycyclic aromatic radical containing from 6 to 14 carbon atoms;
heteroaryl is a mono- or polycyclic heteroaromatic radical containing from 5 to 14 atoms, of which 1 to 5 atoms may be a heteroatom selected from the group consisting of S, O, N and NR5; and optionally substituted means that one or more of the hydrogens on the group are optionally replaced with halo, OH, C1-6alkyl, OC1-6alkyl, fluoro-substituted C1-6alkyl, fluoro-substituted OC1-6alkyl, aryl or aryl that is substituted with 1-5 substituents independently or simultaneously selected from the group consisting of fluoro, C1-4alkyl, OC1-4alkyl, fluoro-substituted C1-4alkyl and fluoro-substituted OC1-4alkyl.
2. The compound according to claim 1, wherein R1 and R2 are independently or simultaneously optionally substituted C3-10cycloalkyl or aryl.
3. The compound according to claim 2, wherein R1 and R2 are independently or simultaneously selected from the group consisting of cyclopropane, adamantyl and phenyl.
4. The compound according to any one of claims 1-3, wherein R3 and R4 are H.
5. The compound according to any one of claims 1-3, wherein R3 and R4 are linked to form an optionally substituted 6-membered ring system.
6. The compound according to any one of claims 1-5, wherein the optional substituents are selected from the group consisting of F, methyl, ethyl, isopropyl, OCH3, CF3, OCF3, phenyl and phenyl that is substituted with 1-3 substituents independently or silumtaneously selected from the group consisting of F, methyl, OCH3, CF3 and OCF3.
7. The compound according to claim 6, wherein phenyl is further substituted with OC1-6alkyl.
8. The compound according to any one of claims 1-7, wherein a is 1.
9. The compound according to any one of claims 1-8, wherein M is selected from the group consisting of Fe, Ru, Os, Co, Rh, Ir, Ni, Pd and Pt.
10. The compound according to claim 9, wherein M is selected from the group consisting of Fe, Ru, Rh, Ir, Pd and Pt.
11. The compound according to claim 10, wherein M is Pd or Pt.
12. The compound according to any one of claims 1-11, wherein L is selected from the group consisting of pyridine, pyriazine, imidazole, quinoxaline and quinoline, all of which are optionally substituted.
13. The compound according to claim 12, wherein L is selected from the group consisting of in which R6, R7, R8, R9 and R10 are independently or simultaneously selected from the group consisting of H, halo, OH, C1-6alkyl, OC1-6alkyl, C3-7cycloalkyl, OC3-7cycloalkyl, fluoro-substituted C1-6alkyl, fluoro-substituted OC1-6alkyl, aryl or aryl that is substituted with 1-5 substituents independently or simultaneously selected from the group consisting of fluoro, C1-4alkyl, OC1-4alkyl, fluoro-substituted C1-4alkyl and fluoro-substituted OC1-4alkyl.
14. The compound according to claim 13, wherein R6, R7, R8, R9 and R10 are independently or simultaneously selected from the group consisting of H, halo, C1-10alkyl, C3-17cycloalkyl and aryl.
15. The compound according to claim 14, wherein R6, R7, R8, R9 and R10 are independently or simultaneously selected from the group consisting of H, Br, Cl, C1-6alkyl, fluoro-substituted C1-6alkyl, C5-6cycloalkyl and phenyl.
16. The compound according to claim 15, wherein R6, R7, R8, R9 and R10 are independently or simultaneously selected from the group consisting of H, CH3, CF3, Br, Cl and phenyl.
17. The compound according to claim 13, wherein R5 or R9 on the N-containing aromatic heterocycle is bonded to M in place of one or more X.
18. The compound according to any one of claims 12-18, wherein L is
19. The compound according to any one of claims 1-18, wherein X is F, Br, Cl, I or OC(O)CH3.
20. The compound according to claim 19, wherein X is Cl or Br.
21. The compound according to claim 1, selected from wherein R is H, methyl, ethyl, isopropyl, OCH3, CF3, OCF3 or F, and M, X, b, and L are as defined in claim 1.
22. The compound according to claim 1, selected from
23. The compound according to claim 1 which is:
wherein R1, R2, R3, R4, M, ~ and X are as defined in claim 1.
wherein R1, R2, R3, R4, M, ~ and X are as defined in claim 1.
24. The compound according to claim 1 which is:
25. The compound according to any one of claims 1 to 24, wherein the compound is attached to a solid support.
26. A method of preparing a compound of formula I according to claim 20, the method comprising:
combining a salt of an N-heterocyclic carbene, a ligand L and a metal salt MXb in the presence of a base to form a reaction mixture; and separating the compound of formula I formed in the reaction mixture;
wherein the N-heterocyclic carbene is wherein R1 to R4, M, b and L are as defined in claim 1 and Y is any suitable anion.
combining a salt of an N-heterocyclic carbene, a ligand L and a metal salt MXb in the presence of a base to form a reaction mixture; and separating the compound of formula I formed in the reaction mixture;
wherein the N-heterocyclic carbene is wherein R1 to R4, M, b and L are as defined in claim 1 and Y is any suitable anion.
27. The method according to claim 26, wherein Y is selected from the group consisting of F-, CI-, Br-, I- and PF6-.
28. The method according to claim 26 or 27, wherein the base is CS2CO3, K2CO3, Na2CO3, K3PO3, CaCO3 or NaOAc.
29. The method according to any one of claims 26-28, wherein the reaction mixture is at a temperature of about 20 to 90°C.
30. The method according to any one of claims 26-29, wherein the reaction mixture further comprising a solvent.
31. The method according to any one of claims 26-30, wherein the compound of formula I is separated from the reaction mixture by purification techniques selected from the group consisting of filtration, recrystallization, extraction, chromatography and combinations thereof.
32. A method for performing a metal-catalyzed cross-coupling reaction comprising: contacting suitable cross-coupling substrates with a compound of formula I according to any one of claims 1-25, under conditions for the formation of cross-coupling product, to form a reaction mixture; and, optionally separating the cross-coupling product from the reaction mixture; wherein the compound of formula I is converted to an active catalyst under suitable reaction conditions in the reaction mixture.
33. The method according to claim 32, wherein the metal-catalyzed cross-coupling reaction is a Negishi coupling reaction, a Heck coupling reaction, a Suzuki coupling reaction, a Hiyama coupling reaction, a Sonogashira coupling reaction, a Stille coupling reaction, a Kumada coupling reaction, a Buchwald-Hartwig amination reaction, an allyl substitution reaction, an enolate arylation reaction, a hydroformylation reaction, a carbonylation reaction, a hydrosilylation reaction or a boronylation reaction.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA 2556850 CA2556850A1 (en) | 2005-08-24 | 2006-08-23 | Transition metal complexes of n-heterocyclic carbenes, method of preparation and use in transition metal catalyzed organic transformations |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71048705P | 2005-08-24 | 2005-08-24 | |
US60/710,487 | 2005-08-24 | ||
US71086905P | 2005-08-25 | 2005-08-25 | |
US60/710,869 | 2005-08-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2551412A1 true CA2551412A1 (en) | 2007-02-24 |
Family
ID=37770774
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2551412 Abandoned CA2551412A1 (en) | 2005-08-24 | 2006-06-30 | Transition metal complexes of n-heterocyclic carbenes, method of preparation and use in transition metal catalyzed organic transformations |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2551412A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110922286A (en) * | 2019-11-23 | 2020-03-27 | 上海化工研究院有限公司 | Asymmetric aryl substituted fulvene compound and preparation method and application thereof |
CN113355075A (en) * | 2021-05-27 | 2021-09-07 | 长江大学 | Thickened oil viscosity reducer and preparation method and application thereof |
US20210308660A1 (en) * | 2018-08-31 | 2021-10-07 | N.E. Chemcat Corporation | Cross-coupling reaction catalyst |
-
2006
- 2006-06-30 CA CA 2551412 patent/CA2551412A1/en not_active Abandoned
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20210308660A1 (en) * | 2018-08-31 | 2021-10-07 | N.E. Chemcat Corporation | Cross-coupling reaction catalyst |
US12017208B2 (en) * | 2018-08-31 | 2024-06-25 | N.E. Chemcat Corporation | Cross-coupling reaction catalyst |
CN110922286A (en) * | 2019-11-23 | 2020-03-27 | 上海化工研究院有限公司 | Asymmetric aryl substituted fulvene compound and preparation method and application thereof |
CN110922286B (en) * | 2019-11-23 | 2022-08-16 | 上海化工研究院有限公司 | Asymmetric aryl substituted fulvene compound and preparation method and application thereof |
CN113355075A (en) * | 2021-05-27 | 2021-09-07 | 长江大学 | Thickened oil viscosity reducer and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7250510B2 (en) | Transition metal complexes of N-heterocyclic carbenes, method of preparation and use in transition metal catalyzed organic transformations | |
JP5591714B2 (en) | Ligands for transition metal catalyzed cross coupling and methods of use thereof | |
Nishina et al. | Late transition metal-catalyzed hydroamination | |
AU2012302599B2 (en) | Process for producing N-(hetero)arylazoles | |
Jadhav et al. | A Merrifield resin supported Pd–NHC complex with a spacer (Pd–NHC@ SP–PS) for the Sonogashira coupling reaction under copper-and solvent-free conditions | |
CN102153592A (en) | Suzuki-Miyaura coupling reaction of catalyzing aryl chloride by N-heterocyclic carbine-palladium-imidazole complex at room temperature under condition of water phase | |
Liu et al. | Synthesis of N-heterocyclic carbene–PdCl 2–(iso) quinoline complexes and their application in arylamination at low catalyst loadings | |
Xu et al. | Ionic Ni (II) complexes containing a triphenylphosphine ligand and an imidazolium cation: synthesis, structures and catalysis for aryl Grignard cross-coupling of aryl halides | |
CA2655575A1 (en) | New ruthenium complexes as catalysts for metathesis reactions | |
Li et al. | Efficient access to a designed phosphapalladacycle catalyst via enantioselective catalytic asymmetric hydrophosphination | |
CA2556850A1 (en) | Transition metal complexes of n-heterocyclic carbenes, method of preparation and use in transition metal catalyzed organic transformations | |
Naghipour et al. | Crystal structure of a novel polymorph of trans-dichlorobis (triphenylphosphine) palladium (II) and its application as a novel, efficient and retrievable catalyst for the amination of aryl halides and stille cross-coupling reactions | |
EP1885669A1 (en) | Nucleophilic heterocyclic carbene derivatives of pd(acac)2 for cross-coupling reactions | |
Li et al. | (IPr) Pd (pydc)(pydc= pyridine-2, 6-dicarboxylate)–A highly active precatalyst for the sterically hindered C–N coupling reactions | |
González-Lainez et al. | N-methylation of amines with methanol catalyzed by Iridium (I) complexes bearing an N, O-functionalized NHC ligand | |
CA2551412A1 (en) | Transition metal complexes of n-heterocyclic carbenes, method of preparation and use in transition metal catalyzed organic transformations | |
Türkmen et al. | Aqueous-phase Suzuki–Miyaura cross-coupling reactions catalyzed by Pd-NHC complexes | |
Iranpoor et al. | 1, 3, 2, 4-Diazadiphosphetidines as ligand and base for palladium-catalyzed Suzuki–Miyaura, Sonogashira–Hagihara, and homocoupling reactions of aryl halides under heterogeneous conditions in water | |
Oloyede et al. | N-Donor 2-(sulfonamido) benzamide ligands, their palladium (II) coordination species and C–C coupling catalysis efficiencies | |
Sinha et al. | [6, 5] CNN Palladium (II) Pincer Complexes Containing N-Substituted Monoanionic and Dianionic Guanidinate Ligands: Syntheses, Structural Aspects, and Their Utility in Suzuki–Miyaura Coupling Reactions | |
CN103748065B (en) | The manufacture method of 2-alkenyl amine compound | |
Merzouk et al. | Synthesis of chiral iminoalkyl functionalised N-heterocyclic carbenes and their use in asymmetric catalysis | |
Shi et al. | Palladium-catalyzed aminations of aryl halides with phosphine-functionalized imidazolium ligands | |
KR20150014852A (en) | Method for preparation of amide and imide from alcohol and nitrogen Containing Compound | |
JP2018140985A (en) | Method for production of aromatic compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |